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ABSTRACT 
Multiple sclerosis (MS) is a common, incurable, demyelinating disorder of 
humans which predominately affects 20-40 year olds, the majority being 
women. MS affects over 10,000 Australians, with a prevalence of 18/100,000 
in Queensland (Hammond 1987; McLeod 1994). The demand for health 
services by people with MS varies with individuals and the levels of the 
disability experienced. The present study of 40 people with MS looks at 
mainstream medicine and complementary therapies accessed by people with 
MS and the cost of these therapies. The unmet needs and concerns of people 
with MS were also documented. 
Results of this study show that a high percentage of the study subjects (82.5%) 
were users of complementary therapy as an adjunct to mainstream medicine. 
All study participants were users of mainstream medicine. The use of 
physiotherapy and the Multiple Sclerosis Society of Queensland (MSSQ) was 
increased as disability worsened, with unemployed persons more likely to use 
community health facilities than employed persons. 
There was a higher use of complementary therapies by females compared with 
males (93% vs 54%); and by patients with the relapsing-remitting type of MS 
(94%) compared with secondary progressive MS (75%) or those with primary 
progressive MS (70%). More tertiary educated people used complementary 
therapies than those with no tertiary qualifications (100% vs 79%). 
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The cost of using complementary therapies for people with MS ranged from $5 
to $725 per month ($100 median). Most people spent less than $20 on any one 
therapy. These findings are consistent with other studies that show the use 
and cost of complementary therapies in chronic incurable diseases is 
substantial. 
Study participants were given opportunity to express issues of concern and/or 
unmet needs. Twenty nine of the 40 subjects (72.5%) raised issues primarily 
relating to problems of transportation, lack of knowledge about MS by some 
health professionals and difficulty in accessing services for MS sufferers and 
their carers. The remainder expressed no concerns or unmet needs. 
In conclusion, the results of this study show that people with MS are heavy 
users of complementary therapies. Mainstream medical providers need to be 
aware of this high use of complementary therapies by people with MS and 
discuss the potential harm in the consumption and use of unproven treatments 
with the patients. 
GLOSSARY OF TERMS 
Acupuncture 
Hypnotherapy and imagery 
Massage and bodywork 
Biofeedback 
• Tai chi 
Chiropractic therapy 
the insertion of hair thin needles into specific 
points on the body, which is a traditional part of 
Chinese medicine for over 2,000 years. 
using either enhanced suggestibility, an altered 
state of mind and behaviour, guided imagery 
used with relaxation, biofeedback hypnosis, 
meditation. 
massage has been used in ancient cultures for 
thousands of years. Some popular western 
massages include Swedish, deep tissue, 
reflexology, polarity therapy, reiki, therapeutic 
touch, Feldenkrais and Alexander techniques. 
translates skin temperature, muscle 
contractions, blood pressure, pulse, brain 
waves and other body functions into audio or 
video signals thereby aiding the patient to learn 
to control body process. 
a blend of exercise and energy work, by using 
slow arm movements that are controlled and 
shifting body weight from one foot to the other. 
began in the late 19"" century using 
manipulation methods of protruding parts of 
spinal vertebrae 
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ADEC Australian Drug Evaluation Committee 
ADRAC Adverse Drug Reactions Committee 
CMEC Complementary Medicines Evaluation Committee 
CNS Central nervous system 
EAE Experimental autoimmune encephalomyelitis 
EDSS Expanded disability status scale 
HIV Human immunodeficiency virus 
HLA Human leukocyte antigen 
MRI Magnetic resonance imaging 
MS Multiple sclerosis 
MSSQ Multiple sclerosis society of Queensland 
PP MS Primary progressive MS 
RR MS Relapsing-remitting MS 
SP MS Secondary progressive MS 
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Chapter 1 Introduction 
There are many chronic, debilitating and incurable diseases afflicting people in 
society. A number of these such as arthritis, human immunodeficiency virus 
(HIV) infection and multiple sclerosis (MS) remain incurable and progressively 
disabling. These diseases are the focus of intensive research and scientific 
investigation, which will, in time, provide answers and better treatments for 
people suffering from these diseases. However, in the meantime, patients 
struggle for many years to cope with the burdens of their disease. 
Multiple sclerosis is a common demyelinating incurable disease which 
predominately affects 20 - 40 year olds, the majority being women. When 
diagnosed with MS the person is faced with an uncertain future, with a disease 
which may cause moderate to severe disability. The demand for health 
services by people with MS varies with individuals and depends on the level of 
disability experienced and the emotional and personal situation of the individual 
(Hainsworth 1994). MS has a profound effect on the lives of individuals and 
also the family members and carers. From conversations with people with MS, 
it appears that issues relating to complementary therapy and the cost of its use, 
play a significant role in the lives of people with MS. 
This study documents the most frequently used services, health therapy 
options, both mainstream and complementary, and the cost involved for people 
with MS. 
Chapter 2 Literature Review 
2.1 Multiple Sclerosis - General Overview 
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the 
central nervous system (CNS) (Pender, 1995). It is the most common CNS 
disease of young adults and causes significant disability. A study in 1986 by 
Hammond et al. (1987) showed that, in Queensland, the prevalence of MS is 
18/100,000. Lesions of MS were first described by Carswell in 1835 
(Compston,1988), although diseases with symptoms resembling MS have been 
described as early as the 14th century (Adams, 1989). MS is a chronic 
disabling disorder which is incurable, although recently some immunological 
modulatory therapies have been introduced that may modify the course of the 
disease. 
2.1.1 Clinical features of MS 
MS may commence as early as the age of three years (Hanefield et al., 1991), 
or as late as the seventh decade, but it generally presents between the ages of 
15 and 50 years (Confavreaux et al., 1980, Weinshenker et al., 1989). There 
appears to be a relationship between age of onset and the sex of the patient 
(McAlpine, 1991); in childhood MS and early-adult-onset MS, twice as many 
females as males develop MS. In contrast, MS presenting after the age of 40 
usually affects more males than females. 
The most common neurological symptoms and signs of MS are shown in Table 
2.1 (McAlpine, 1991; Pender, 1995): 
Table 2.1 Common neurological signs and symptoms of MS 
• visual loss, due to optic neuritis. 
• weakness of the lower limbs, with or without upper limb weakness. 
• sensory loss or numbness of the limbs or trunk. 
• sensory or unsteady gait. 
• bladder and bowel disturbance. 
• cognitive impairment - poor concentration, recall difficulties 
• cranial nerve symptoms and signs (double vision, facial sensory 
disturbance) 
• nystagmus 
The signs and symptoms may occur in an episodic fashion with each episode 
being regarded as an 'attack' of MS. The clinical features of an attack of MS 
may remit completely or in part, may remain stationary for a prolonged period, 
or may progress. Some studies have shown a strong positive correlation 
between rapidity of onset and degree of recovery, with a lesser relationship 
between recovery and the severity or nature of the symptoms (McAlpine, 1991). 
The greater the degree of recovery from a relapse the better the expectation of 
remission in the next relapse. 
2.1.2 Types of MS. 
Several distinct types of MS are recognized on the basis of the clinical course. 
Classification of the types of MS is as follows. These are relapsing remitting 
MS (RR-MS), secondary progressive MS (SP-MS), and phmary progressive MS 
(PP-MS). The most common and typical course is one of relapses and 
remissions (RR-MS). Patients with RR-MS may later develop a gradually 
progressive pattern of neurological deficit which is known as secondary 
progressive MS (SP-MS). About one-third of MS patients experience a 
progressive course without experiencing any obvious discrete attacks or 
remissions during their illness; this is known as primary progressive MS (PP-
MS) (McAlpine, 1991). Patients who develop MS at a later age often present 
with PP-MS (Cazzullo et al., 1978; Weinshenker et al., 1989), and their 
prognosis is often relatively poor. For a few patients, MS takes an acute rapidly 
progressive course known as Marburg's disease, or acute MS (Lassmann et al., 
1981) in which death occurs within three weeks to six months after the onset of 
the first clinical signs. 
2.1.3 Pathophysiology of the neurological deficits in MS 
The major cause of the neurological deficits in MS is conduction block due to 
primary demyelination of nerve fibres. However, loss of axons can also occur 
in MS (Barnes et al., 1991) and is likely to be an important cause of persistent 
disability. In most MS patients, pathology is restricted to the CNS myelin, in 
particular the optic nerves, spinal cord and cerebral white matter. However, 
there is also some evidence of peripheral nervous system (PNS) involvement in 
a small percentage of patients with typical MS (Waksman, 1993) 
2.1.4 Prognosis of MS 
It is difficult to predict prognosis, however the following factors, shown in Table 
2.2, suggest a poor prognosis (Clanet 1995): 
Table 2.2 Factors suggesting a poor prognosis 
• a progressive course from disease onset 
• age at onset greater than is usual ( > 40 years) 
• male gender 
• a short time between the first two exacerbations (attacks) 
• a high frequency of exacerbations 
The most common causes of death in MS are infections due to the paralysed 
state of the patient, unrelated disease, and occasionally suicide; death from a 
direct effect of MS on the nervous system is uncommon. 
2.1.5 Measurement of Multiple Sclerosis Disability - The Expanded 
Disability Status Scale (EDSS) 
The Expanded Disability Status Scale (EDSS) (Kurtzke, 1983) is a scoring 
system specifically designed to rate the degree of disability in a person with 
MS. This score concentrates on lower limb involvement and mobility. A low 
score (1 - 4) indicates mild disability with full ambulation; an EDSS of 5 - 6 
demonstrates impairment with disability severe enough to impair full daily 
activities; an EDSS of 6 - 7 indicates a requirement for intermittent or unilateral 
support to walk about 100 metres. When a person has a higher score (7 -10 ) 
they will require bilateral assistance or wheelchair mobility. For example a 
person with a score of 7.5 is unable to take more than a few steps and is 
essentially restricted to a wheelchair, requiring the assistance of attendants or 
carers for maintenance of acceptable living standards. The EDSS has been 
criticised because it primarily assesses lower limb function. Other tests, used 
less commonly, such as the Nine Hole Peg Test, evaluate upper limb motor 
weakness and/or sensory loss. 
2.2 Causes of multiple sclerosis 
The cause of MS is unknown. However it is thought that factors important in 
the aetiopathogenesis of MS are genetic predisposition and autoimmune 
mechanisms. The epidemiology of MS (see below) suggests that 
environmental factors may trigger MS. 
2.2.1 Genetic predisposition 
The involvement of a genetic factor in the pathogenesis of MS is suggested by 
the following lines of evidence: 
Twin studies. Twin studies showing greater concordance of MS in monozygotic 
than dizygotic twins suggest that inheritance is important for MS susceptibility 
(Ebersetal., 1986). 
l-luman Leucocyte Antigen (i-IU\) and MS. Population studies have found a 
relationship between the class II alleles DR 15 and DQ6 and MS susceptibility 
(Olerupetal., 1989). 
Genetic background. Although there is evidence showing that MS occurs in all 
three of the main racial groups in the world (white, oriental and black), 
regardless of the country in which they are living, the highest incidence has 
been reported in areas of the wortd with a majority white population (McAlpine, 
1991). Orientals, Eskimos and North American Indians have low rates of MS 
(Detels et al., 1977). 
Genome Screening. Studies of the entire genome of patients with familial MS 
indicate that a number of genes may be involved in MS susceptibility 
(Compston 1997). 
2.2.2 Autoimmune mechanisms 
It is postulated that the immune system has a dormant pool of autoreactive T 
cells including cells that can cause inflammation or demyelination of the CNS. 
These become activated when triggered by an unknown factor. Activated T 
cells may then cross the blood brain barrier and be stimulated by exposure to 
an antigen in the CNS. Inflammation results and damage to the myelin and 
oligodendrocytes occurs (Pender 1995). There is increasing evidence that MS 
is an autoimmune disease with pathological features of MS being reproduced in 
laboratory animals by immunisation with myelin antigens. This immunisation 
induces a disease known as experimental autoimmune encephalomyelitis 
(EAE). EAE is used to investigate disease processes relevant to MS (Pender 
1996). 
2.3 Epidemiology of MS 
2.3.1 World wide incidence and prevalence 
It is estimated that there are 2,500,000 people with MS in the world 
(International Federation of MS Societies 1998). MS is common in Northern 
Europe, North America and Australia but rare in the Orient, Asia, the Indian 
subcontinent, Africa and South America. Compston (1997) documents the 
epidemiology of MS. Prevalence of MS in Europe varies from 280/100,000 in 
Scotland; 100/100,000 in southern England; 105/100,000 in Denmark; 
110/100,000 in Switzerland; 35/100,000 in Italy; in North America prevalence 
ranges from 65/100,000 in the west coast; 110/100,000 in the midwest and 
70/100,000 on the east coast of the United States; 120/100,000 in British 
Columbia, Canada. It has been suggested that the distribution of the disease, 
varying with latitude (more distant from the equator the higher the prevalence of 
MS), reflects the involvement of an environmental factor in the aetiology 
(Limberg, 1950). 
Several clusters of cases of MS have been reported which also suggest a 
viral/bacterial aetiology for MS. The best known of these was in the Faroe 
Islands: MS was almost unknown there before World War II; however, after 
occupation by British troops many cases were reported, and the prevalence is 
now one of the highest in the world, 300/100,000 population (Kurtzke et al., 
1995). A cluster of cases related to a zinc factory in Rochester NY (Stein et al., 
1987) suggested that other environmental factors may also play a role in 
triggering MS. Exacerbations of MS have been related to upper respiratory 
tract infections (URTI) (there is a threefold higher incidence of exacerbations in 
patients with URTI) (Sibley et al., 1985). Exacerbations of MS can be triggered 
by stressful life events (Franklin et al.,1988). ft has been shown that MS 
prevalence is increased in higher socioeconomic groups, in which smaller 
families, larger houses and better personal and family hygiene tend to postpone 
infection until later ages (Waksman, 1989). 
2.3.2 Multiple Sclerosis in Australia and Queensland 
MS affects over 10,000 Australians. The exact number of people with MS in 
Queensland at present is not known, however an exhaustive study by 
Hammond was carried out in 1987 when the Queensland population was 
2,295,122. There were 420 documented cases of definite and probable MS, 
in the whole of Queensland giving a prevalence of 18/100,000. South of the 
Tropic of Capricorn, 356 cases were identified, a prevalence of 20.9/100,000, 
compared with a prevalence of 11.8 above the Tropic of Capricorn (Hammond 
et al 1987). It is interesting to note that MS is a rare disease amongst the 
Aboriginal and Torres Strait Islander populations, with no cases being 
documented in Hammond's study nor any previous studies (Hammond et al 
1987). 
The increasing prevalence with increasing south latitude was confirmed by 
McLeod et al (1994), for example, in Tasmania, MS has a prevalence of 
75/100,000, a three fold increase when contrasted with Queensland 18/100,000 
(Hammond et al 1987). 
Historically, Queensland has had a high population migration rate from the 
people of United Kingdom and Ireland, both known high risk groups. It has 
been shown that if people migrate before the age of 15 they take on the risk of 
the new geographical location, however, if migration occurs after the age of 15 
years of age, the high risk status is maintained (Dean and Kurtzke 1971: Detels 
et al 1978). This suggests that there may be some event occurhng prior to the 
age of 15 which has an impact of the development of MS in an individual. 
2.4 Diagnosis of MS 
Diagnosis is made by detailed clinical history and physical examination, usually 
by a specialist neurologist. The diagnosis is based on the clinical examination 
as well as other investigations including magnetic resonance imaging (MRI), 
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examination of the cerebrospinal fluid (by performing a lumbar puncture) and 
visual evoked responses (Pender, 1996). 
The diagnosis of relapsing remitting MS requires evidence of two separate 
attacks involving different parts of the CNS occurring over a period of months. 
Primary progressive MS is more difficult to diagnose and, like relapsing 
remitting MS, there is a time element involved documenting the progressive 
neurological deterioration with clinical, MRI or neuropsychological evidence of 
new lesions in the CNS (Pender 1996). Secondary progressive MS occurs 
when a person with RR MS does not recover from the last attack and 
consequently experiences a worsening of the disease without subsequent 
remissions. 
2.5 Drug Therapies for multiple sclerosis 
There are a number of drugs used to treat MS, but no known cure. The therapy 
of MS can be divided into treatment of the disease process and treating the 
symptoms. 
Therapy for the disease process can be further divided into treatments given to 
speed recovery from an acute attack and treatments intended to reduce the 
rate and severity of future attacks. High dose methyl prednisolone is given 
intravenously to patients with a moderate to severe attack of MS to hasten 
recovery. This is administered in daily infusions over a five day period. Mild 
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attacks are not always treated as these do not severely limit the daily life 
activities of the patient. Intravenous methylprednisolone is also used for 
patients who have chronic progressive disease which may respond when the 
disease is worsening at a rapid rate (Pender, 1996). 
Prevention of further deterioration is a major concern for people with MS and, in 
1996, a beta interferon therapy was made available. The annual cost for 
treatment of one patient with beta interferon is $A14,000, subsidised in 
Australia by the Commonwealth Government. This drug, self injected every 
second day, has been shown to reduce the severity and number of attacks for 
people with relapsing remitting MS (The IFBN Multiple Sclerosis Study Group, 
1993). The same study has also shown some benefit in reduction of brain 
lesions seen on magnetic resonance imaging (MRI) after treatment for two 
years. Other therapies which are used with some limited success include 
immunosuppressants, plasmapheresis and intravenous gammaglobulin. 
Symptomatic treatments are important as problems such as spasticity, 
neuralgic pain, paroxysmal symptoms, fatigue, urinary problems and impotence 
require specialised assessment and appropriate treatment regimes. Symptoms 
may be reduced in severity but often the patient is left with symptoms which are 
mild to moderate. 
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2.6 Use of Health Services by people with MS 
2.6.1 Mainstream Medicine 
The demand for health services by people with MS varies with individuals, the 
levels of the disability experienced and the individual differences of emotional 
and personal needs. (Hainsworth 1994). Chronic diseases have both physical 
and mental components and are permanent features of the person's life. For 
people with MS there is an ongoing dependency on physicians, other health 
practitioners, therapeutic regimes and surgical procedures (Verbrugge and 
Patrick 1995). 
A study by Black et al. (1994) provided an extensive demographic profile of the 
social and service needs of people with MS living in New South Wales. In 
Black's study, 40% of the people with MS were managing personal needs 
themselves, with 50% requiring either their partner's help or a family member. 
Only ten percent were using health professionals for daily care and activities of 
daily living. Physiotherapists, urologists, social workers, occupational 
therapists, community nurses and psychologists were all listed by patients as 
health professionals significantly involved in the ongoing care and management 
of MS. The patients in this study identified a lack of knowledge of MS of health 
professionals as a barrier to the delivery of appropriate health care to patients 
with MS. 
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2.6.1.1 Professional Health Service Providers 
Family physicians (general practitioners) are primary health care providers and 
are strategic in the delivery of holistic health care. The role of general 
practitioners is diverse, providing and coordinating health care for individuals 
with complex needs. In Australia, the family physician is seen as the primary 
health professional that people in the community approach for health 
information, direction and support for their health needs. 
Patients with MS in New South Wales were asked to rate the most important 
health professional in the ongoing management of their MS (Black et al 1994). 
The family physician was listed as the most important health provider, with 
neurologists and other allied health workers ranked in decreasing importance. 
This primary care approach has a dual role in enabling and prioritizing the wide 
variety of patients' needs and providing an avenue for developing the patient-
doctor relationship during the ongoing health care process (Stange 1998). 
People with MS, particularly those with progressive disease, require a family 
physician committed to providing a link between health services and resources 
of the health care system. In Australia, the family physician (general 
practitioner) is generally the primary health care provider. 
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Neurologist. In the USA, Enteen (1995) surveyed 358 patients with MS. In 
this study 56% of patients identified their neurologist as the primary care 
physician, while 32% viewed the general practitioner as primary care provider. 
This is in contrast with Australia, where the health system requires that a 
patient has a referral from his or her general practitioner to specialist doctor. 
The neurologist is the relevant medical specialist consultant for people with MS. 
Allied health professionals, occupational therapists, speech pathologists and 
physiotherapists have a major role in the care of the disabled person. DiFabio 
et al. (1998) studied 46 MS sufferers with progressive disease, half of whom 
were given rehabilitation treatment programmes for one year, involving weekly 
outpatient visits and supervised rehabilitation sessions, while an untreated 
placebo group were put on a 'waiting list' for one year. They concluded that 
outpatient rehabilitation programmes for persons with MS, in particular those 
with progressive forms of MS, had an important role in the management of 
symptoms of fatigue and physical well being. They also showed that through 
this rehabilitation programme there was preservation of physical and cognitive 
functioning and also the facilitation of interaction within existing family networks. 
Patients on this programme had significantly fewer symptoms and also an 
improved quality of life. 
Multiple sclerosis specialty clinics also have a role to play for people with MS 
and these clinics can support the central role of the GP in delivery of 
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appropriate and accessible health care. The specialty clinic provides expert 
opinion in the continuing management of people with MS and can be involved 
in the treatment of exacerbations and complications of the disease process. 
Specialty clinics are common place in the United States and there is a trend in 
Australia to provide such clinics. One MS specialty clinic in Queensland is 
located at the Royal Brisbane Hospital and in other Australian states and 
territories, outpatient clinics are held in major city hospitals. 
2.6.1.2 Support Services 
Support services for people with MS are diverse. Support groups find their 
impetus from within the local community of people with MS and their carers. 
Self help groups have been established in both city and rural communities and 
are self managed. 
Multiple Sclerosis Society of Queensland (MSSQ) 
The MSSQ provides assistance for the people with MS in Queensland. People 
registered with the MSSQ are able to access sen/ices at no cost ($10 yearly 
registration fee). The list of sen/ices provided is shown in Table 2.3. 
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2.6.2 Complementary Therapies 
2.6.2.1 Definition 
There is no strict definition of complementary therapy, Complementary 
therapies cover a diverse range of practices and can generally be described as 
non proven therapies and practices that have not been scientifically 
documented as safe and effective. For the purpose of this thesis 
complementary therapy will be defined as those therapies not prescribed by 
recognized medical practitioners. A practice such as counselling, which may be 
a component of mainstream management of MS, would thus be classed as 
complementary if it was prescribed by an alternative therapy practitioner. 
These therapies may be used concurrently with prescribed medications or as 
an alternative therapy. 
They arise from different traditions and historical backgrounds, and include 
acupuncture, guided imagery, chiropractic, yoga, hypnosis, biofeedback, 
aromatherapy, homeopathy, relaxation techniques, reflexology, traditional 
Chinese medicine, macrobiotics, iridology, and various schools of massage. 
Wanning (page 349, 1993) describes the use of complementary therapies as 
"viewing the body and mind as a balanced whole" which through techniques 
such as massage, acupuncture, t'ai chi and feldenkrais facilitate healing 
through relaxation, pressure points and movement. Different complementary 
therapies may have different theoretical and philosophical bases. 
17 
Table 2.3 Services provided bv the MS Society of Queensland (MSSQ) 
• accommodation and respite care for the person with MS 
• physiotherapy - initial assessment and treatment plan for individuals and a 
referral system to a local public hospital physiotherapy department or private 
therapist 
• counsellors for individuals and their families and advice and support with 
employment issues. 
• allied health support and assessment including occupational therapy, speech 
pathologist and psychological support 
• programme co-ordinators and case management for the MS sufferer and the 
family unit 
• financial assistance and ways to access loans 
• children's support programmes and support groups for people with MS 
• outreach to country areas for patients, health professionals and community 
workers 
• advice on transport and services available in the community 
• support to access recreational and leisure activities 
• community education and training of volunteers 
• advice and hire of equipment and aids for activities of daily living and home 
comfort 
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2.6.2.2 Use of Complementary Therapies 
There is a world wide trend, reported by European, North American and 
Australian investigators, for increased use of complementary therapies by 
populations who are suffering illness and also by those who are well. 
(Maddocks, 1985, Fulder and Munro, 1985, Clinical Oncology Group, 1987). 
United States 
Eisenberg et al., (1993) surveyed 1539 healthy American adults to find the 
prevalence of use of unconventional therapies. They found that one in three 
adults reported using at least one unconventional therapy in the past year, one 
third of these visiting alternative therapists. The vast majority (85%) of those 
with a serious illness, also sought treatment for the same condition from a 
medical doctor. Paramore (1997), analysing data from 3450 normal subjects, 
showed that nearly 10% of the 'well' US population saw an alternative therapist. 
Anderson et al (1993) recruited 184 HIV positive patients, from three HIV clinics 
in the Philadelphia area, into a study which investigated the extent of recourse 
to alternative therapies while attending mainstream medical clinics for disease 
management. Forty two percent of subjects reported using complementary 
therapies. 
Studies into other chronic, debilitating incurable diseases have shown that the 
use of complementary therapies is widely practiced. Cronan (1989) in San 
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Diego, in a study of musculoskeletal diseases, found that as many as 90% of 
people with these disorders used complementary therapies. Donnelly et al 
(1985) demonstrated that 45% of people suffering from asthma had consulted 
alternative practitioners at some time, most popularly chiropractors and 
homeopaths. 
A centre for evaluating alternative medicine in the treatment of HIV/AIDS was 
established in October 1994 in Seattle, Washington. This centre is currently 
evaluating therapies for HIV/AIDS in conjunction with a network of alternative 
therapy clinics in the United States. The aim is to determine whether patients 
who use both alternative therapies and conventional medicine have different 
outcomes from patients who only use conventional therapies (Standish et al 
1997). 
Canada 
Millar (1997) estimated that 15% of Canadians, surveyed in 1994-95, used 
some form of alternative therapy. Among persons free of chronic illness, Millar 
found that 9% consulted alternative therapist compared with over 26% of those 
suffering a chronic disease. 
Singh et al., (1996), in a study of the use of nontraditional therapy by people 
with HIV infection, documented that 30% of the subjects used such therapies. 
Singh et al showed that recourse to non-traditional therapies was common 
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amongst people who are HIV infected, not because they are depressed or 
emotionally disturbed, but because they seek greater control of the outcome of 
their disease. There was, however, no beneficial effect of the disease 
progression when compared with patients receiving only conventional medical 
therapy (Singh et al 1996). 
Netherlands 
Another study of HIV patients, in the Nethertands, demonstrated that over 
30% of patients were using alternative therapies (Wolffers and deMoree1994). 
Norway 
Of 642 respondents to a Nonwegian study of cancer patients, 20% had been or 
were users of alternative therapies for their oncological disease (Risberg et al 
1995). Risberg et al., documented the incidence of nonproven therapy use 
amongst cancer patients as 45% in a five year prospective study, which also 
showed that women were more frequent users of complementary therapies 
than men (50% vs 31%, P=.002). Risberg et al. showed that non proven 
therapies did not influence survival amongst cancer patients in north Nonway 
and also showed a trend that complementary therapies are most often used by 
people from a higher socioeconomic background and with higher education 
(P=0.06) (Risberg et al., 1998). 
Thus, it is not unusual for people with chronic diseases, nor in fact for the 
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general population, to use complementary therapies. 
Australia 
In Australia, MacLennan et al (1996) sun/eyed 3004 persons aged 15 and older 
living in South Australia. Forty-eight percent of those interviewed had used at 
least one complementary therapy in the last year, while 20.3% of all survey 
participants had visited at least one alternative practitioner. 
Lloyd (1993) studied a population of 289 Australians with an extensive array of 
ailments, for whom allopathic medicine had been unsuccessful. All the subjects 
resided in Sydney. Almost half (41%) the sample population had attended an 
alternative therapist for over a year, while another 11% had commenced 
complementary therapy within six months prior to the survey. These therapies 
were not reimbursed by Medicare. 
A major public hospital in metropolitan Sydney assessed the patterns of 
alternative medicine used in its public hospital oncology unit which showed a 
21.9% use of alternative therapies (Begbie et al., 1996). The investigators 
concluded that a significant number of cancer patients were using one or more 
alternative therapies, and proposed that this usage may reflect deficiencies in 
the standard of care given. 
The Australian Federal Government has recently implemented several 
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initiatives in the area of scientific standard for complementary therapies. The 
CMEC (Complementary Medicines Evaluation Committee) in parallel to the 
ADEC (Australian Drug Evaluation Committee) meets on a regular basis to 
consider new items on the market and reconsiders old items if there are current 
safety issues. The ADRAC (Adverse Drug Reactions Committee) considers all 
reported drug reactions in Australia and has for the last two years included 
reactions from complementary medicines. 
2.6.2.3 Reasons for using complementary therapies. 
The reason why people use complementary therapies is multifactoral. Donnelly 
et al., (1985) identified well individuals and individuals with used both 
complementary therapies and orthodox medicine. Donnelly et al. concluded 
that there was no support for the view that users of alternative therapies were 
disgruntled with orthodox medicine. 
As previously mentioned, patients infected with human immunodeficiency virus 
(HIV) are turning to non traditional therapy (Singh, 1996) which, although there 
is no proven impact on the long term outcome of the disease, gives greater 
control to the patient in process of managing their disease. Astin (1998) 
studied 1035 randomly selected well individuals from the United States, who 
had agreed to participate in mail surveys, and found that they did not use 
alternative therapy because they were dissatisfied with conventional medicine 
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but as an adjunct. Alternative therapies were found to be more congruent with 
their own values, beliefs and philosophical orientations toward health and life. 
Fawcett et al. (1994) demonstrated that, while 100 percent of MS sufferers in 
the study population living in New England area of USA, confinued under the 
primary care of a physician, 63% were concurrently visiting an alternative health 
practifioner. Anecdotal evidence has suggested that there is concurrent use of 
both complementary therapies and mainstream treatments within health care 
sen/ices by people with MS. 
2.6.2.4 Issues associated with using complementary therapies 
Increased use of complementary therapies has caused some concern amongst 
mainstream conventional medical practitioners. 
There is a potential harm to the consumer of these complementary treatments. 
A small study in Ireland discussed the impact of alternative medicine on renal 
function (Farrell et al., 1995). Physicians observed three nephrotoxic 
individuals who suffered irreversible renal impairment due to ingestion of 
complementary therapies. 
Patients may abandon appropriate proven therapy to pursue potentially harmful 
alternative therapies and McGinnis (1991) has called for public and professional 
education to discuss the role and dangers involved in the use of 
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complementary therapies. Brigden (1995) pointed out that physicians need to 
discuss with their patients any questionable therapies that may be in vogue in 
their geographical and medical specialty areas. LaValley and Verhoef (1995) 
suggested that documentation of patient use of complementary therapies 
should become a part of the complete patient medical history. This may 
promote greater patient-physician communication and consequently enhance 
the quality of care. 
Exploitation of patients by unscrupulous therapists is possible and McKnight 
and Scott (1996) pointed out that doctors who are aware and educated about 
their patients' use of non proven therapies would be in a better position to 
defend and advise their patients against exploitation or unsafe treatment. 
Anderson et al (1993) stated that medical practitioners and other health care 
workers need to be aware of their patients' interests and priorities and work with 
them in decision making about their treatment regimes in order to achieve 
satisfactory outcomes. 
Another important issue of complementary therapy use is the paucity of safety 
and efficacy data. This raises major concerns for public health. Another 
concern is that use of complementary therapy may incur large costs by 
individuals. There is also the possibility that a person using an alternative 
therapy could delay consultation with a physician who may have therapy that 
will benefit the pafient. Freeman et al (1997) sees the challenge for health care 
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providers as responding appropriately to the notable prevalence of alternative 
health pracfices and the complex societal factors that nurture their usage. 
2.7 Impact and economic cost of multiple sclerosis 
2.7.1 Quality of Life 
Quality of life for people with MS deteriorates early in the disease process and 
worsens as further disability and physical functioning becomes affected. It has 
been estimated that 85% of people with MS are disabled to some degree 
because of their MS (Canadian Burden of Illness Study Group 1998). 
Disablement may mean restrictions in opportunities for employment, limiting 
activities of daily living activities and also difficulfies in relating to others 
(McLennan et al., 1996). 
MS can impose limitations in all areas of life. Multiple sclerosis, as previously 
stated, is usually progressive in nature, often leading to physical and 
sometimes mental deterioration (Confavreaux et al., 1980, Weinshenker, 1989). 
The uncertainty of the disease course and the disabling affects of the disease 
have profound impact on the lives of individuals, family members and carers. 
For the individual, impairment of physical, cognitive and emofional faculties can 
result in strained relationships within the family situation, socially and in the 
work place. 
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The need for help, the risk of divorce, loss of contact with relatives, difficulty 
with going out and the need for changing house structures to accommodate the 
worsening physical handicap place people with MS under a great social and 
economic strain (Stenager et al., 1994). Some people diagnosed with MS 
withdraw from intimate relationships or choose not to inform their families or 
friends of their MS. 
Physically disabling symptoms experienced by people with MS have a 
significant impact on their ability to maintain daily life activities. Unsteady gait 
and balance disturbances may cause fear of mobility and frequent falls. Loss 
of co-ordination can result in apparent 'clumsiness' and difficulty in carrying out 
routine self care activities. Simple message writing or buttoning clothes can 
become difficult tasks, and on days when the person is experiencing a 
worsening of their disease, these simple tasks become impossible to 
accomplish (Rudick 1990). Coping with such stresses in the individual's 
personal life requires a network of supportive people and resources (Murray 
1995). 
Many people with MS suffer embarrassment because of loss of control of 
bladder and bowel function. This loss of control may cause urinary or faecal 
frequency, urgency or incontinence, sometimes in public places. Eye problems, 
such as blurring of vision, double vision and sometimes loss of vision may 
occur for days or weeks, making daily activities, car driving and mobility difficult 
27 
if not impossible. Pain and altered skin sensation along with unsteady gait and 
loss of proprioception make it difficult for the individual to be mobile. Sensory 
and motor disturbances can cause major impact on patients. A 1998 survey of 
198 MS Canadian patients, showed that early in the MS disease process, using 
a Quality of Life generic assessment (SF- 36), there was a substantial 
reducfion in the quality of life compared with the normal population. As the 
persons' disability worsened, so too did the quality of life (The Canadian Study 
Group 1998). 
2.7.2 Economic cost of MS 
The cost of health care for people multiple sclerosis is large, both to the 
individual and the community as a whole. The cost of MS in a number of 
western societies has been studied and is summarised below. 
United States 
There are an estimated 350,000 people with MS in the United States (Fawcett 
et al 1994). In the United States, in a study of 606 people with MS, the national 
annual cost of medical care, personal services, alteration to home, vehicles, 
purchase of special equipment and earnings loss was in the billions of dollars 
(Whetton-Goldstein et al 1996). Bourdette et al (1993), have shown that over 
half the total number of individuals with MS in the United States, became 
unemployed because of the disease within 10 years of their diagnosis. The 
average cost of MS, per person per year, was $US34,103 with the largest cost 
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being lost wages, averaging $17,900 per person annually. The breakdown of 
these costs included care giving by family members ($US6,452), home and 
person assistance by paid care givers ($US1,247), hospital costs ($US2,485), 
physicians costs ($US1,746), medications ($US $US847), nursing home care 
($US845), retraining ($US944) and other costs ($US556). The investigators 
found that for people with the progressive form of MS, the costs were much 
higher, averaging $US49,084/person/year (Whetton-Goldstein et al 1998). The 
cost to the individual with MS varies according to individual needs and disease 
severity. Enteen (1995) states that one of four American MS families cannot 
meet basic living expenses with their current family income, and long term care 
is a major problem for most, as the majority are under-insured. 
Canada 
There are an estimated 35,000 people with MS in Canada (The Canadian 
Burden of Illness Study Group 1998). It was estimated that the total cost for all 
Canadians with MS in 1994 was $CDN502.3 million, which included both direct 
costs (hospital care, other institufions, physician services, other health 
professionals and drugs) and indirect costs (loss of productivity due to 
premature mortality and disability) (Asche et al 1995). The annual costs per 
patient were calculated from provincial data showing a range of $CDN 14,523 to 
$CDN37,024 for patients with increasing mild to severe disability, defined using 
EDSS. In all these groups most of the financial burden is borne by the patients 
themselves (from 74% to 88%). The major costs to society were lost daily 
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activity and lost productivity. The life time cost of MS, including pafient 
institutionalisation was estimated at $CDN1,608,000 per patient (Canadian 
Burden of Illness Group, 1998). 
United Kingdom 
There are approximately 85,000 people with MS in the UK (Hatch, 1996) In 
1994, the total annual cost of mulfiple sclerosis to the state and National Health 
Service in the United Kingdom was 1.2 billion pounds. These figures are based 
on a questionnaire circulated to 999 people with MS in the UK. The major 
financial burden, 536 million pounds per year, is borne by the individuals and 
families affected by MS. The greatest economic loss is from lost earnings, but 
also includes cost of child care, housing alterafions and purchase of special 
supplies and equipment. Hatch documents the cost to the State in financial 
benefits paid and lost tax revenue is 435 million pounds per year and the cost 
to industry in lost productivity amounts to over 40 million pounds per year. A 
significant economic burden is also borne by the family and non professional 
carers, who have to be absent from paid work in order to provide care for the 
person with MS (Holmes et al 1995, Hatch 1996). 
Holmes et al (1995) points out that while the health care systems of the UK and 
USA are different, "disabling, long term illness imposes a significant economic 
hardship on families afflicted with illness and on members of the society as 
well" (1994 Inman). Indirect costs, such as lost daily activity and lost 
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productivity are a major economic burden to society (The Canadian Burden of 
Illness Group 1998). The costs need to be considered by health service 
delivery systems in order to set priorities for research and treatment activities. 
The cost is ulfimately shared by individuals and society as a whole. 
Australia 
The cost to the health care system, for the estimated 10,000 people with MS in 
Australia, has not yet been documented. However, it would be likely to mirror 
that of the Canadian and UK experience where Hatch (1995) states that the 
economic burden of MS, to the individual and the state, is significant. 
2.7.3 The economic cost of complementary therapies. 
The cost of these complementary therapies is not included in health care costs 
as listed above. 
The United States 
Eisenberg et al., studied 1539 adults in North America (1993). They found that 
one in four Americans who see their medical doctors for a serious complaint 
were using non prescribed therapy in addition to mainstream prescribed 
medicine for that specific problem. Seven of ten of such occurrences took 
place without patients telling their medical doctors that they used 
unconvenfional therapy. Eisenberg et al also state that the number of visits in 
1990 to providers of unconventional therapies was greater than the number of 
31 
visits to all primary care medical doctors nationwide. The amount of money 
spent out of pocket ($US10.3 billion) for unconvenfional therapies was 
comparable to the amount spent out of pocket by Americans for hospitalizations 
($US12.8 billion), and just under half the amount spent for all physicians' 
services ($US23.5 billion) in 1990. Not only people with serious complaints 
were using complementary therapies. At least one in three individuals with 
back problems, anxiety, depression or chronic pain, were using 
nonconvenfional therapies without disclosing this to their physician. As 
Eisenberg et al state "unconventional medicine has an enormous presence in 
the US health care system" (1993). 
Of 1,811 people living in metropolitan San Diego, United States, 382 reported 
having musculo-skeletal complaints. Eighty-four percent of the 382 subjects 
had used complementary therapies within the previous 6 months (Cronan et al 
1989). Commonly used remedies included prayer (44%), non prescribed 
exercise (33%), relaxation (33%) and whirlpool/hot tub treatments (29%). Sixty-
one per cent of people using hot tubs stated that they were very helpful, and 
prayer was rated by 54% of the users as being very helpful. Cronan et al found 
that the use of expensive unconvenfional therapies was uncommon. Their 
finding suggests that the use of unconventional therapies is widespread but the 
most popular therapies are neither harmful nor expensive. They state that the 
remedies may provide patients with a sense of control over their disease 
(Cronan etal., 1993). 
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The use and types of alternative therapies were assessed in 3004 people in a 
South Australian community by MacLennan et al. (1996). In the year 1992/93 
extrapolation of the costs to the Australian population, gives an expenditure of 
$A621 million per annum for alternative medicines and $391 million per annum 
for consultation with alternative therapists. A total of $1 billion per year to the 
Australian populafion. When this is contrasted with the total amount spent in 
by all Australians on pharmaceutical drugs ($360 million per year), expenditure 
on complementary therapies is quite significant. These figures raise public 
health issues of safety and efficacy when use of complementary therapy is 
used by a large number of the total populafion (MacLennan et al., 1996). 
Complementary therapy for people with MS. Fawcett et al. (1994), in a small 
American study of 16 people with MS, found that eight (50%) of the study 
participants, had spent more than $US1000 for alternative treatment in the past 
year. Thirty seven percent reported spending more than $US10,000 on 
alternative therapy since their MS symptoms began. Some of the 
complementary therapies used included touch therapy, acupuncture, 
naturopathy, homeopathy and herbal medicine. Forty four percent of people 
stated that the quality of their lives was improved by alternative therapies. 
In Australia, there are no studies which specifically address the use of 
complementary therapies in mulfiple sclerosis. 
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2.7.4 Unmet Needs of Patients with MS 
In a preliminary study of 358 people with MS, when asked for evaluations of 
their medical care, the most common complaint by respondents was "lack of 
caring" by health providers (28%), followed by "lack of knowledge about MS" 
(22%) and "failure to diagnose" (19%) (Enteen 1995). 
It has been demonstrated that emotional needs of the person with MS are of 
major importance in managing ongoing care. According to Black (1994) the 
physical needs of the person are more often met than the emotional needs. 
Main areas of concern for the person with MS were loss of employment, 
fatigue, lack of respite care and need for extensive family support. People with 
MS felt that the lack of understanding about the disease by family members 
caused breakdowns of relationships in their family network. Approximately 30% 
of the patients stated that their needs were not met in areas of long and short 
term breaks from home and in receiving support from other people with MS. 
Support networks, such as self help groups, and aids to allow independence in 
acfivities of daily living, were not being provided for people with severe physical 
disability. Williams and Bowie showed that, in patients with MS, there was a 
high prevalence of unmet needs to accomplish daily life activities as the 
physical disability worsened (1993). 
This finding is not confined to MS. In HIV/AIDS pafients, 20% of the pafients 
identified lack of non institufional services, such as mental health support, as a 
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major area of unmet needs by health providers (Bonuck et al 1996). Pafients 
with chronic diseases attending medical clinics in Portland, Oregon, stated that 
their desire for emofional support and informafion regarding their disease were 
the two most frequently unmet needs (Joos et al 1993). Patient satisfaction 
with medical care received was seen to be compromised and this jeopardised 
health outcomes. A similar finding was described by Allen and Mor, (1997) 
when patients with a physical disability in Rhode Island, USA, were 
invesfigated to determine the prevalence and consequences of unmet needs. 
Inadequate help in daily activity areas such as eating, transferring (moving from 
bed to chair or toilet), cooking, heavy housekeeping and transportation, 
impeded the management of chronic health conditions and compromised the 
individual's ability to maintain a safe and reasonable quality of community living. 
2.8 Rationale for the Present Study 
Documentation of the use and cost of both mainstream and complementary 
therapies is required in order to understand the needs of people with multiple 
sclerosis (MS). Documentation of the extent of use and cost of complementary 
therapies serves as part of the holistic approach to health care. The present 
study of complementary therapies arose from personal observation by the 
investigator who had had close regular contact with many people with MS over 
a three year period. It became evident that there was a heavy use of 
complementary therapies by people with MS and that for some people this 
involved considerable financial outlay. It was also apparent that the taking of 
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these medications caused anxiety for individuals who were seeking approval 
and direcfion in the area of complementary therapies. 
2.9 Aims and Objectives of the Present Study 
The aim of the present study was to document the services accessed by people 
with MS, and to identify what mainstream medicines and complementary 
therapies were used, how frequently and at what cost. This is the first such 
study in Australia. 
The study used a questionnaire to interview subjects concerning the use of 
mainstream medical services and complementary therapies. It was not within 
the scope of this study to determine effectiveness of complementary 
therapies. 
2.10 Hypotheses 
The study examines four main hypotheses. 
1. That people with MS access a range of mainstream sen/ices according to 
their needs 
2. That many people with MS use complementary therapies. 
3. That there is a wide range in the cost of complementary therapy to 
individuals 
4. That people with MS are using complementary therapy as an adjunct therapy 
with mainstream therapies in managing their MS 
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Chapter 3 Methodology 
3.1 Introduction 
People with mulfiple sclerosis live with the uncertainty of a disease which 
cannot be cured and a disease process which is usually progressive in nature. 
Documentation of the use and cost of both mainstream and complementary 
therapies was required in order to understand the needs of people with multiple 
sclerosis. The data were obtained by interview and administrafion of a 
questionnaire developed by the investigator who had close regular contact with 
many people with MS over a three year period. The emphasis on 
complementary therapy emerged as it became evident that there was a heavy 
use of complementary therapies by people with MS in this group and that for 
some people this involved considerable financial oufiay. The use of 
complementary therapies was a common theme in many conversafions with 
people with MS. 
3.2 Development of the Questionnaire 
3.2.1 Preliminary 
The quesfionnaire was based on other questionnaires used by the invesfigator 
in previous multiple sclerosis research projects and specific quesfions raised by 
people with MS about complementary therapies. The quesfionnaire was 
designed to document the cost and use of mainstream and complementary 
therapies. Core informafion on demographic and MS disease informafion was 
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included in order to classify individuals by MS types, duration and severity of 
disease. 
3.2.2 Focus group 
A preliminary questionnaire was produced to detail demographic, mainstream 
health services and complementary therapies used and the cost of these to the 
consumer. The investigator read through the questions to the focus group of 
three MS patients. The investigator had a prepared quesfionnaire for discussion 
and as comments were made by the focus group participants, the investigator 
scribed, collated and incorporated these into the final draft of the 
quesfionnaire. 
From discussions with these individuals it was decided that the best approach 
was a face to face interview, in the patient's home when possible, with the 
interviewer recording the responses. This was suggested because patients 
have problems with fafigue, transport difficulties and mobility. It was also 
suggested that some questions be 'open ended' to allow for comments about 
health services, complementary medicine and other issues that are of concern 
to the person with MS. This part of the interview became the source of the list 
of 'unmet needs' of patients with MS. 
38 
3.2.3 Questionnaire 
The quesfionnaire consisted of 5 pages (Appendix A). Ethics approval was 
given by Royal Brisbane Hospital ethics committee and a signed consent by the 
participant was obtained. An informafion sheet was provided, indicafing the 
study objecfives, patient privacy procedures and the interview process. 
The questionnaire consisted of four secfions. 
a) demographics 
b) the frequency of mainstream health seryices accessed and the cost involved 
c) the frequency and cost of complementary therapies used 
d) health care services - open ended quesfions allowing for documentation of 
services areas of major concern. 
3.3 Study Population 
3.3.1 Criteria for participation in the study 
• A diagnosis of definite MS from medical records 
• To give consent for a personal interview. 
• To have adequate English speaking skills 
• Newly diagnosed MS patients were excluded 
3.3.2 Number of study subjects 
Everyone who attended the hospital for an appointment or who was phoning for 
another reason, was approached to participate in the study. Some people were 
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also participafing in other MS research projects carried out in the hospital. All 
forty people that were approached agreed to be participants in the study. All 
the interviews were carried out over a 6 month period. 
3.3.3 Interview Process 
Once the patient had consented to participation, the time and place of the 
interview was scheduled. The majority of the patients lived within four hours 
car journey from Brisbane and interviews were carried out at home. On four 
occasions the interview was carried out in the hospital clinic. 
Fatigue. An important consideration in this study was that people with MS are 
easily fatigued. This is a well documented feature of the disease. As 
involvement in the study would require commitment to an interview and a 
quesfionnaire, extra effort was required from the patient and it was envisaged 
that the interview process would cause fatigue. To accommodate pafients, 
considerafion was given to the time of day that the interview was carried out. 
The majority of interviews were scheduled in the morning, when the pafient is 
less fatigued. 
Personal needs. Many patients required attention for personal needs and also 
assistance with roufine morning schedules. Carers, for the more disabled, 
needed fime to manage and support the patient's personal needs prior to the 
arrival of the interviewer. Due considerafion was given to arrange this interview 
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so that neither the patient nor the carer felt undue pressure prior to or during 
the interview process. 
Extent of disability. Another factor dictating the inten/iew process was the 
nature and extent of the patient's disability. Some subjects experienced 
significant weakness, incoordinafion of the hands and consequently could not 
sign consent forms. Verbal consent to participate in the study was given by 
these people, witnessed by their family member or carer. Other patients had 
impaired vision (either loss of vision or blurred vision) and consent forms and 
explanations of the project needed to be read. 
Cognitive impairment. Some patients were not able to concentrate for an 
extended period of fime and therefore small breaks were included between 
quesfions. The interviewer therefore documented all interviews herself, as 
attenfion span and physical exertion waxes and wanes for the patient with MS. 
Transportation. Travelling to the person's home, or a mutually convenient place 
was negotiated on a person to person basis. Transportafion can cause 
significant logisfic difficulties and physical limitations for the person with MS. 
This factor, along with the effort required for the patient in walking with the use 
of sticks and mobility frames, meant that where possible, interviews were held 
at the person's home. The interview, which lasted approximately one and half 
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hours was most suitable in the home situafion as it provided the best 
environment to carry out the interview. 
The study population represented people who were able to speak about their 
disease and who already had contact with the health system. Some people 
with mild MS are able to manage small disease fluctuafions without seeking 
the help and support of medical services, and would not have been part of the 
group targetted for this study. 
3.4 Data Collection and Analysis 
Table 3.1 Interview Data 
age, sex, employment status 
educafional qualificafions 
disease types 
durafion of disease 
disability profile (EDSS) - Kurtzke's rafing of neurological impairment 
mainstream health services used 
complementary therapies used 
cost of mainstream therapies 
cost of complementary therapies 
patient safisfaction with complementary therapies 
unmet needs / general comments 
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The data collected were stored using Excel and Microsoft Access. All 
completed quesfionnaires were entered into an Excel Database and analysed. 
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Chapter 4 Results 
4.1 Demographics 
Forty people were approached and all agreed to participate in the study. All the 
study subjects were diagnosed with definite MS. There were no newly 
diagnosed subjects. 
4.1.1 Age and gender 
Table 4.1 shows the age and gender of patients included in this study. The 
study subjects ranged in age from 27 to 68 years, with the majority of pafients 
(70%) between 40 to 59 years of age and only 13% greater than 60. The mean 
age was 49 years. 
Table 4.1 Age and Gender of MS Patients 
Age Distribution 
tTotel 
20-39 
40 -49 
50-59 
60 and older 
Number 
40 
7 
11 
17 
5 
% 
Tpo i 
17.5 
27.5 
42.5 
12.5 
Sex 
Male 
Female 
^^ -
29 
28.0 
72.0 
The data were compared with the only previous study on MS in Queensland 
(Hammond 1987). There was a statistically significant difference between the 
age of the two populafions, with Hammond et al. having a younger populafion 
(mean age 33 years) (Chi square p=0.02). Of the 40 pafients, 28 (70%) were 
between 40 - 59 years old, 22 (55%) were older than 50 years and only 7 were 
44 
under the age of 39 (17.5%). As all newly diagnosed pafients were excluded, 
the study populafion were further into their disease course and more likely to be 
older. 
The rafio of 29 females (72%) to 11 males (28%) is consistent with Hammond 
(70.1% females and 29.9% males) and reflects the known rafio of prevalence 
of MS in females and males of approximately 2:1 (Pender 1996). 
4.1.2 Employment and Educational Qualifications 
Table 4.2 shows the employment status of patients in the present study. Just 
over one third (35%) of those in the study had either part time or full fime 
employment while 26 of the 40 subjects (65%) were on a pension, (with only 5 
of these being sixty years or older). 
Table 4.2 Employment and Educational Qualifications 
Employment Si^ tut 
Employed 
Pensioner 
#40 
14 
26 
M 
35 
65 
Educational Qiiailifications 
Secondary School 
Tertiary Studies 
33 
,_,_,X 
82.5 
17.5 
Those with employment were in clerical, engineering or teaching professions. 
Tertiary qualifications were held by 17.5% (7) subjects. 
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4.1.3 Disease Category and Duration of the Disease 
Table 4.3 shows the categories of disease and durafion of disease of pafients in 
the present study. Of the forty subjects, 18 (45%) had relapsing remitfing MS; 
12 people (30%) had secondary progressive MS and 10 (25%) primary 
progressive MS. 
Table 4.3 Disease Categories and Duration of Disease 
Disease Categpryj ^ 
Total 
Relapsing Remitting 
Secondary Progressive 
Primary Progressive 
Duration of Disease (yrs 
<5 
5-10 
>10 
Number 
40 
18 
12 
10 
y . - ' : : „ . : „, , 
8 
13 
19 
% 
700 
45 
30 
25 
20.0 
32.5 
47.5 
The majority of patients had been diagnosed more than 5 years previously. 
Seventy five percent (18/40) of the people with MS had begun the disease 
course as relapsing remitting MS (RR) with 30% (12/40) having progressed to 
secondary progressive disease (SP) by the fime of the study. 
4.1.4 Disability measured bv EDSS 
Table 4.4 shows the disability status of patients in the study. The Expanded 
Disability Status Score (EDSS) demonstrates a wide range of independence / 
disability in the study population. 
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The majority (75%) of patients are ambulatory with EDSS 1-7, (35% needing 
some support or aids and 40% are fully ambulatory). The remaining ten people 
(25%) had severe disability (EDSS > 7.5) essenfially restricfing them to 
wheelchair mobility. 
Table 4.4 The disability status of patients in the study 
EDDS - (Expandd(f Disability Stdtus Scale) 
^ " _ ' 
1 -5.5 
Fully ambulatory without aid 
6 -7 
Ambulatory with assistance 
or aid 
7.5-9 
Restricted to wheelchair 
Number 
16 
14 
10 
% 
40 
35 
25 
One patient, was completely dependent on her partner for all daily activities. 
This patient was able to swallow thickened fluids with difficulty, use her eye lids 
for communication and had very limited head and eye movement. 
4.1.5 EDSS and Duration of Disease by Disease Categories 
Table 4.5 shows the disability status, according to disease category and 
disease durafion. Within individuals, it is expected that the disease course will 
worsen the disability of SP patients. Six of the ten people with an EDSS 
greater than 7.0 fell into the secondary progressive group. These people had a 
disability which basically restricted them to a wheelchair, often motorised 
(EDSS category of 7.5) There were 16 people (11 of whom had relapsing 
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remitfing MS) with an EDSS score of less than 5.5. This indicated that for this 
group the disability was severe enough to impair full day activifies. Individuals 
in this category may not, however, be able to work a full day without special 
provisions. 
Table 4.5 EDSS and Duration of Disease bv disease Categories 
EDSS Disability Score 
Relapsing 
Remitting 
Number % 
Secondary 
Progressive 
Number % 
Primary 
PrdgresSive 
Number % 
1 -5.5 
6 - 7 
7.5-9 
Total 
11 
5 
2 
18 
61 
28 
11 
1QQ 
1 
5 
6 
n 
8 
42 
50 
too 
4 
4 
2 
10 
40 
40 
20 
wo^ 
Duration of Disease (years) 
< 5 years 
5-10 years 
> 10 years 
Total 
2 
6 
10 
18 
11 
33 
56 
100 
1 
4 
7 
12 
8 
33 
58 
100 
5 
3 
2 
10 
50 
30 
20 
100 
Of those with relapsing remitting MS only 2 individuals had an EDSS greater 
than 7, while 50% of those with secondary progressive MS (6/12) had an 
EDSS greater than 7. This shows the subjects in this study had an increasing 
severity of the disease with progression to the secondary progressive stage of 
MS. 
Of the 18 patients with RR MS, 44% (8 subjects) had MS for less than 10 
years, while 56% (10 subjects) had MS for over ten years, with two individuals 
having had MS for over 25 years. The primary progressive group had 80% (8 
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subjects) with a disease duration of less than 10 years. By definition, the 
people with SP MS had previously been classified with RR MS and had 
progressed to a secondary progressive disease course. Fifty-eight percent of 
SP MS had a disease durafion of over 10 years. 
Table 4.6 Categories of MS bv Age and Sex (RR. SP. PP) 
Relapsing 
Remitting 
Number % 
Secondary 
Pfogressiye 
Number % 
Primary 
Progressive 
Number % 
Age 
20-39 
40-49 
50-59 
60 Scolder 
Total 
4 
7 
6 
1 
is 
22 
39 
33 
6 
100 
3 
2 
5 
2 
12 
25 
17 
41 
17 
100 
-
2 
6 
2 
10 
0 
20 
60 
20 
100 
Sex 
Male 
Female 
Total 
Table 4.6 sh 
4 
14 
18 
lows the cate 
22 
78 
100 
gohes 
3 
9 
12 
of MS by ag€ 
25 
75 
100 
i and c 
4 
6 
10 
40 
60 
100 
jender. Patients with P 0 
MS were more likely to be older and the percentage of males was highest in 
the group with PP MS (40%). 
4.2 Use of Mainstream Health Services 
Table 4.7 shows the use of mainstream health services by patients in the study. 
Because of the way in which they were recruited, all of the study participants 
were attending specialist neurological sen/ices, 38 of 40 subjects (95%) 
regularly (yearly), and 2 of 40 subjects (5%) somefimes (second yearly or when 
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a relapse occured.) All patients also had regular contact with their general 
practitioner who bulk billed. 
Table 4.7 Use of Mainstream Health Services 
Use of 
Mainstream 
Services 
GP 
Specialist 
Physiotherapist 
MS Society 
Community 
Health 
Regularly 
Number 
38 
38 
21 
19 
13 
% 
M§ . 
95 
52.5 
47.5 
32,5 
Sometimes 
NUiiiBier 
2 
2 
2 
13 
2 
% 
5 
5 
5 
32.5 
5 
Never 
Nunibisf 
0 
0 
17 
8 
25 
% 
0 
0 
42.5 
20 
65.5 
Twenty one of forty subjects (52.5%) had regular or infrequent physiotherapy 
appointments. Eighty percent of subjects used the Multiple Sclerosis Society of 
Queensland (MSSQ), 19 of 40 regularly (47.5%), 13 of 40 somefimes (32.5%). 
Fifteen pafients used community based services, (either community nurses or 
home attendant services). 
There was no cost to the patient in attending the neurologist and general 
practitioner. The cost was covered by Medicare. For some employed patients, 
this was through Medicare levy of income. Community health services were 
also at no cost to the individual. 
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4.2.1 Influence of Age and Gender on mainstream services 
Table 4.8 shows the use of mainstream health services by age and gender. 
Table 4.8 Use of Mainstream Services bv Age and Gender 
Age (yrs) 
20-39 
40-49 
50-59 
60> 
Sex 
Male 
Female 
Number 
40 
7 
11 
17 
5 
MSSQ 
n % 
6 
8 
13 
5 
(85.7) 
(72.2) 
(76.5) 
(100) 
Physio 
n % 
3 
7 
10 
3 
(42.9) 
(63.6) 
(58.8) 
(60.0) 
Comm Health 
n % 
3 (42.9) 
4 (36.4) 
6 (35.3) 
2 (40.0) 
11 
29 
10 
22 
(90.1) 
(75.9) 
7 
16 
(63.6) 
(55.2) 
3 (27.3) 
12 (41.4) 
Note: all patients see a general practitioner and neurologist 
Men were slightly more likely to use MSSQ (90% vs 75.9%) and physiotherapy 
(63.6% vs 55.2%). Whereas more women than men (41% vs 27%) accessed 
community health services. 
Patients 60 years and older were highly likely to use MSSQ compared with 
those aged 40 - 49 and 50 - 59 (100% vs 72% vs 76.5%). Community health 
use was not impacted by age with 35.3% - 42.9% use across the 4 age groups. 
Physiotherapy was used less by 20 - 39 year age group, when compared with 
40 - 49, 50 - 59 and >60 years old ( 42.9% vs 63.6%, 58.8%, 60%). 
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4.2.2 Influence of employment and educational level on the use of 
mainstream services 
Table 4.9 shows the use of mainstream services by employment and 
educafional qualifications. A greater number of the unemployed than employed 
accessed mainstream services, in particular, 14 of the 26 (54%) unemployed 
patients accessed community health services compared with only 1 of the 14 
(7%) employed persons. This may suggest that those working were less 
disabled and were able to carry out activities of daily living, without requiring the 
assistance of community health nurses or attendants. 
Table 4.9 Use of Mainstream Services bv Employment and Educational 
Levels 
Employment 
Yes 
No 
EdUcatibh 
Qualification 
Secondary 
Tertiary 
Number 
40 
MSSQ 
n % 
Physio 
n % 
Comm Health 
n % 
14 
26 
33 
7 
10 (71) 
22 (85) 
26 (79) 
6 (86) 
6 (43) 
17 (65) 
19 (58) 
4 (57) 
1 (7) 
14 (54) 
14 (42) 
1 (14) 
Fourteen pafients (42%) with non tertiary educafional qualifications used 
community health services, compared with 1 of 7 (14%) persons with tertiary 
educafion. This may be explained by the fact that tertiary qualified people (5 of 
the 7 tertiary qualified people were employed) had access to employment that 
was not requiring as much physical ability to perform tasks in the work place. 
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The other mainstream services were used equally by both secondary and 
tertiary educated people with MS. 
4.2.3 Influence of disease duration, disease category and EDSS on use of 
mainstream services 
Table 4.10 shows the use of mainstream services by disease durafion, disease 
category and disability (EDSS). Access to all services was increased as 
disability worsened. The MSSQ was used by 62.5% with a low EDSS (< 5.5) 
and 100% of the patients with a high EDSS (7.5 and greater). 
Table 4.10 Use of Mainstream Services bv Disease Duration. Disease 
Category and EDSS 
EDSS 
1-5.5 
6-7 
7.5-9 
Disease 
Duration 
(yrs) 
<5 
5-10 
>10 
Disease 
Category 
RR 
SP 
PP 
Number 
16 
14 
10 
8 
13 
19 
18 
12 
10 
MSSQ 
n % 
10 (62.5) 
12 (85) 
10 (100) 
5 (62.5) 
10 (77) 
17 (89.5) 
13 (72) 
11 (91.5) 
8 (80) 
Physio 
n % 
7 (43.75) 
9 (64.5) 
7 (70) 
4 (50) 
6 (46) 
13 (68.4) 
10 (55.5) 
7 (58.3) 
6 (60) 
Community 
Health 
n % 
3 (18.7) 
6 (42.8) 
6 (60) 
3 (37.5) 
5 (38.5) 
7 (36.8) 
6 (33.3) 
6 (50) 
3 (30) 
As disease durafion increased there was an increase in the use of MSSQ (62.5 
% to 89.5%) except physiotherapy. (50% to 68.4%) but not community health. 
53 
People with SP MS were more likely to use MSSQ and community health 
services than people with RR MS and PP MS. 
4.3 Complementary Therapy 
Thirty three of 40 (82.5%) study subjects using complementary therapies. 
Table 4.11 shows the different complementary therapies used. Therapies 
have been grouped into non prescribed medications and physical/psychological 
therapies. See Appendix B for detailed descripfion of some of these therapies. 
Table 4.11 Complementary therapies used bv study patients 
Non prescribed medications 
• evening primrose oil 
• dietary manipulafion 
• naturopathy 
• vitamin supplements 
• kambucha 
• shark extract 
• bee venom 
• picnogyl 
• marihuana 
• aromatherapy 
• oxichel 
Physical /psychological therapies 
• counselling 
• polarity 
• kinesology 
• colour light therapy 
• prayer and meditafion 
• massage 
• feldenkrais 
• reiki 
• lymphosizer 
• bowen technique 
• acupuncture 
One subject used a combination of homoeopathy, vitamins (both oral and 
injected), acupuncture, naturopathy, touch for health, a powder additive to milk, 
kambucha tea, chiropracfic techniques, aromatherapy, feldenkrais, therapeufic 
massage, herbal creams, colour light therapy and bowen technique. 
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4.3.1. The influence of age and gender on use of complementary therapies 
Table 4.12 shows the use of complementary therapies by age and gender. 
Thirty three of the 40 subjects (82.5%) used complementary therapies. Of the 
male subjects, 6 (54%) used complementary therapies. In contrast, 27 of the 
29 women, (93%) were users of complementary therapies. This difference is 
statistically significant ( j ^ p = 0.016). 
Table 4.12 Use of complementary therapy bv age and gender. 
Total Number 
fSex 
Male 
Female 
Use of ComplementaryTherapy 
; Yes (%) 
33 (82.5) 
No (%) 
7 (17^5) 
1 Total 
40 
6 (54.5) 
27 (93.1) 
5 (45.5) 
2 (6.9) 
11 
29 
lAge (yrs) 
20-39 
40-49 
50-59 
60 > 
7 (100) 
11 (100) 
11 (64.7) 
4 (80) 
0 
0 
6 (35.3) 
1 (20) 
7 
11 
17 
5 
All the 18 subjects aged 20 - 40 years old were users of complementary 
therapies. Fifteen of 22 (68%) subjects over the age of 50 were users of 
complementary therapy. 
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4.3.2 Employment and educational qualifications 
Table 4.13 Use of Complementary Therapy bv Employment and 
Educational Levels. 
Total Number 
Employment 
Employed 
Unemployed 
Educational Level 
Secondary Educafion 
Tertiary Education 
Use of ComplementaryTherapy 
Yes(%) 
33 (82.5) 
No (%) 
7(17.5) 
Total 
40 
12 (85.7) 
21 (80.7) 
2(14.3) 
5(19.3) 
14 
26 
26 (78.8) 
7(100) 
7(21.2) 
0 
33 
7 
Table 4.13 shows use of complementary therapies by employment and 
educafional qualifications. The use of complementary therapies was similar in 
both employed and unemployed groups. However, 100% of the tertiary 
qualified subjects used complementary therapies compared with 79% of those 
with secondary qualifications 
4.3.3 Patient satisfaction with complementary therapy 
While this study was not intended to assess the efficacy of complementary 
therapies. Table 4.14 shows general patient satisfacfion with such therapies. 
The use of complementary therapies was perceived to be of good benefit to 24 
(72%) of the users. Three subjects (9.1%) felt that there was no benefit at all 
with 6 patients (18.2%) describing a marginal benefit. 
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Table 4.14 Patient Satisfaction among 33 users of Compfemetitai 
Therapies 
Good Benefit 
Some Benefit 
No Benefit 
Number (Total 33) 
24 
6 
3 
.......^ .S....„.,... 
72.7 
18.2 
9.1 
4.3.4 Influence of disease duration, disease category and EDSS on use of 
complementary therapy 
Table 4.15 shows the use of complementary therapy by disease category, 
disease duration and disability (EDSS). 
Table 4.15 Use of Complementary Therapy bv Disease Category. Disease 
Duration and EDSS. 
Use of ComplementaryTherapy 
Total Nuitiber 
Disease Category 
Relapsing Remitting 
Secondary Progressive 
Primary Progressive 
ipuratibn of Disease 
< 5 years 
5 -10 years 
>1 Oyears 
EDSS 
1 -5.5 
6 - 7 
7.5-9 
Yis (%> 
33(82,5) 
No(%) 
7(17.5) 
Total 
40 
17(94.4) 
9(75) 
7(70) 
6 (75) 
11 (84.6) 
16(84.2) 
1 (5.6) 
3(25) 
3(30) 
2 (25) 
2(15.4) 
3(15.8) 
18 
12 
10 
8 
13 
19 
14 (87.5) 
11 (78.6) 
8(80) 
2(12.5) 
3(21.4) 
2(20) 
16 
14 
10 
Interestingly, of the 18 pafients with a diagnosis of relapsing remi tfing disease, 
17 (94.4%) were using complementary therapies. This compares with 9 (75%) 
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of 12 secondary progressive patients and 7 (70%) of 10 primary progressive 
patients. Neither disability level (EDSS) or durafion of disease had an 
appreciable impact on the use of complementary therapies. 
4.4 Cost of Complementary Therapies 
Figure 1 shows the number of patients spending differing amounts per month 
on complementary therapy. 
Figure 1 Total cost of complementary therapy / person / month 
Number of Patients spending $ / month on Complementary 
Therapies (33 subjects) 
The maximum amount that any one person spent in a one month period was 
$725 dollars. This individual was undergoing mulfiple complementary 
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therapies concurrently. This level of spending was maintained for a period of 
six months. Twelve (36%) spent less that $50 / month while 12 (36%) spent 
between $200 - $725 / month. Twenty four of 33 (73%) study participants used 
two or more complementary therapies. 
Table 4.16 Use and cost to 33 users of complementary therapies 
Complementary 
Therapy Used 
Use of any therapy 
Evening Primrose Oil 
Vitamins - oral 
Naturopathy 
Acupuncture 
Diet / supplements 
Prayer/meditation 
Massage 
Counselling 
Vitamins- intramuscular/ 
intravenous 
Aromatherapy 
Picnogyl 
Kambucha 
Oxichel 
Feldenkrais 
Marihuana 
Bee venom 
Colour light therapy, 
Polarity, Kinesology 
Shark extract 
Reiki 
Bowen technique 
Number 
using 
Therapy 
33 
20 
20 
16 
14 
7 
6 
6 
5 
3 
3 
3 
2 
2 
2 
% 
^ 0 
61 
61 
48 
42 
21 
18 
18 
15 
9 
9 
9 
6 
6 
6 
3 
3 
3 
3 
3 
3 
$ 
Min - max 
/ month 
Q^M 
5-100 
5-200 
10-250 
5-200 
5-180 
0 -20 
20-100 
0-140 
5-120 
5 -20 
80-120 
5 
55 
10-30 
5 
30 
55 
150 
200 
20 
$ 
Median 
/ month 
IM 
15 
20 
50 
80 
20 
5 
55 
50 
100 
10 
100 
Table 4.16 shows the complementary therapies used and the maximum and 
minimum and median cost to the consumers of each therapy. Thirty three of 40 
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patients (82.5%) used complementary therapies. The most frequently used 
complementary therapies by the 33 subjects were, 20 people (60%) using 
evening primrose oil, 20 (60%) using vitamins, 16 (48%) using naturopathy and 
14 (42%) using acupuncture. 
The cost of some therapies was relatively cheap such as evening primrose oil 
(median cost $15/month) when compared with picnogyl ($100/month) and 
intravenous vitamins ($100/month). A number of patients were using 
combination therapies and therefore incurred a greater cost. 
The dosage and frequency of complementary therapies taken by people varied. 
There was often no recommended maximum dose and patients self prescribed 
many of the treatments listed above. Some had visited alternative health 
practitioners to have advice on which therapies should be taken. Pafients used 
combinations of the above therapies with self regulated dosage/therapy 
schedule. Therapies were taken as a preventative measure, or when the MS 
was worsening. 
All of the study participants were accessing mainstream services and only 7 of 
40 were not users of complementary therapy. The use of complementary 
therapies was concurrent with mainstream services use by the large majority 
(82.5%) of this populafion which would indicate that these therapies are seen 
by the users as an adjunct for managing their MS. These results are similar to 
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other studies on the use of complementary therapies carried out by Singh et al., 
(1996) and Eisenberg et al., (1993) 
4.5 Non users of complementary therapies 
There were 7 of 40 (17.5%) non users of complementary therapies. Of these, 5 
were males and 2 females, all were over 50 years of age (median 53) with 6 of 
7 having a progressive form of MS (either SP or PP MS). None had tertiary 
educational qualifications with only one having employment. All these subjects 
accessed general practitioners and neurologists; 5 of 7 (71%) used MSSQ 
services; 4 of 7 (57%) used physiotherapy. Only 1 person of this group used 
community health services. 
4.6 Unmet Needs of patients with MS 
Unmet needs were not the planned focus of this study, therefore these issues 
were not invesfigated in depth nor 'followed through'. In the interview 
discussion, pafients voiced personal concerns and personal or family needs in 
dealing with MS. Details of these issues are documented in Appendix C. 
These concerns have been categorised and are shown in Figure 2 
Eleven of 40 (27.5%) patients expressed no concerns and stated they were 
satisfied with exisfing services. Perhaps these individuals had found 
alternative methods to deal with issues or had 'overcome' past concerns. 
These problems were no longer perceived as a problem for activifies of daily 
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living. Or alternatively, their support network was sufficient to meet their 
personal needs. Some may have simply 'given up'. This would need to be 
explored in more detail. 
Figure 2 
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4.6.1 Transportation 
Transportafion was raised as major concern by 20 (50%) of the subjects 
especially accessing transportation and the difficulties affording suitable 
transport vehicles or adjusfing existing vehicles for wheelchairs. These were 
daily problems for people with MS who required transport in order to maintain a 
level of independence in carrying out activifies of daily living, shopping, visifing 
friends and attending community facilities. Inadequate building access was also 
a problem, with a lack of, or inadequate, parking, ramps, rails, inadequate 
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space for mobility all of which restricted access in some public places. 
Geographical locations of both leisure and health facilities were a problem for 
those outside the main metropolitan area where facilities were not as readily 
accessible or available compared with the metropolitan area. 
4.6.2 Education 
Education about MS and disability was raised by 18 (45%) of the subjects as a 
major need for the community health sen/ices and health professionals. Many 
patients felt that they were unable to access general medical or community 
services that provided adequately informed services. 
4.6.3 MS services 
MS services. 12 (30%) felt that there needed to be better advice on location of 
MS specific resource health personnel and services and also planning for the 
future. Many pafients felt that they could not easily access informafion on 
medical supplies, respite care and accommodation available for ongoing 
support. 
4.6.4 Carers 
Carers, often family members, were identified as a forgotten and ovenworked 
group. Eleven (27.5%) of patients felt that the expectafions placed upon their 
family to provide 24 hour care were inappropriate and too taxing. The whole 
area of 'burden of care' is the subject of interest and research in the wider 
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community as the effects of chronic disease and shorter hospital bed stay days 
mean that families and carers are providing rehabilitation and caring roles. 
4.6.5 Financial concerns 
Financial concerns, were mentioned by 9 subjects (22.5%) because of loss of 
income and also the dependency on social services The cost of medical care is 
subsidised by government through Medicare and public hospitals, however, two 
people specifically menfioned the cost of magnefic resonance imaging which at 
the fime of the this study, was not subsidised by private or Medicare insurance. 
This is no longer an issue since September 1998 as a rebate is now given by 
Medicare and health funds. Medical equipment (urinary catheters, pads, 
specialised cups and utensils for daily living) were either partially or not 
adequately funded for some people who were heavy users of these items. 
4.6.6 Counselling 
Counselling services and emotional support were stated as inadequate by 9 
subjects (22.5%) with services costly and inaccessible for people with MS and 
their carers. 
4.6.7 Complementary therapies 
Complementary medicines and therapies were a concern. Some patients 
thought there should be refunds. Inadequate standards and safety issues of 
taking alternative therapies was also menfioned. 
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4.6.8 Child carers 
Children of people with MS, were major 'care givers' to the person with MS for 2 
pafients, for personal and daily care. This was seen by one patient as 
undesirable although no alternative was perceived by the patient. 
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Chapters Discussion 
People need to have equitable, appropriate, affordable and accessible health 
care, as stated in the Ottawa Charter, which endeavours to: 
" advocate, enable and mediate for good health, equity on health 
care, ensuring equal opportunities and resources to enable all people to 
achieve their fullest health potential. This requires a supportive 
environment, access to information, life skills and opportunities for 
making healthy choices. People cannot achieve their fullest health 
potential unless they are able to take control of those things which 
determine their health." 
(Ottawa Charter for Health Promofion 1986). 
In order to provide this type of health service in Australia to those with MS, the 
system which delivers health services to those with MS must examine its 
current approach and ensure that it incorporates an intersectorai collaboration 
with patients, community and other agencies with an interest in the area. In the 
light of this principle, and with constraints that exist within the health care 
system in Australia, the present study has identified mainstream health 
services accessed, the prevalence of use and cost of complementary therapies 
to the consumer and identified areas of concern and health care practices of 
people with MS in South East Queensland. 
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The present study was of 40 subjects, and studied the use and cost of 
mainstream health services and complementary therapies, and the unmet 
needs of people with MS. 
5.1 Demographics of the study population 
Gender and age. The ratio of females to males (2:1) reflects the known gender 
ratio in MS and is consistent with Hammond's epidemiological survey of MS 
pafients in Queensland (Hammond 1987). There was, however, a statistically 
significant difference between the age groups in the 2 studies, with an older 
populafion in the present study when compared with Hammond's population. 
This difference may be due to the selection process where no newly diagnosed 
patients (therefore younger) were enrolled into the present study. The younger 
newly diagnosed populafion are not well represented in this group. 
In addifion, the study participants were those who had had previous contact 
with the investigator in the care and monitoring of individual health care needs 
and therefore were those how lived within 4 hours drive of Brisbane city. It is 
difficult to know the regional differences that occur in MS population, that would 
make this study group more representative of the total MS populafion in 
Queensland. 
Employment and educational qualifications. Thirty five percent of the patients 
(14 of 40) were employed although only two patients were over 65 years old. 
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indicafing a high unemployment rate for those of working age. Of seven 
subjects who had tertiary qualifications (17.5%), three were now on a disability 
pension. These figures corroborate the findings of others the high impact that 
MS has on loss of income and unemployment (Bourdette et al 1993; Fawcett et 
al 1994; Asche et al 1995; Whetton-Goldstein et al 1996; The Canadian Burden 
of Illness Group 1998). 
5.2 Disease categories, duration and severity 
Disease categories, duration of disease and severity of disease. Proportions of 
patients with RR MS, SP MS and PP MS in the present study (45%, 30% and 
20% respectively) are generally representative of the wider MS populafion and 
reflect the known incidence of disease types (approximately 66%, 
approximately 35% and 9 - 37%) respectively). There is variation in percentage 
depending on the population studied (Weinschenker et al 1989). 
The diversity in disability levels, disease duration and disease types within the 
study population provides insight into different areas of health services for 
people at varying stages of MS. This data shows current needs and concerns 
of this populafion that can be generalised to the population of MS sufferers in 
South East Queensland, recognizing that the newly diagnosed younger group 
are not well represented.. 
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5.3 Use and cost of mainstream medicine. 
The first hypothesis of the present study concerned the use of mainstream 
medicine. All study participants were using at least some mainstream medical 
services, with all participants having a neurological review every 12-18 months 
and seeing a general practifioner on a regular needs basis. This is an expected 
result as all participants were recruited through existing health networks. 
However, the use of health services by people with MS in this study population 
varied with individuals, depending on disability and emofional and cognitive 
requirements, as has also been documented by Hainsworth (1994). 
Neurologists and general practitioners All patients were accessing mainstream 
medical providers on a needs basis. Specialist neurologists were accessed by 
all study participants. This is a recommended practice, as MS can be difficult to 
diagnose (Pender 1996) and the monitoring of the disease course is an 
important part of assessing and managing the individual's MS. General 
practitioners were accessed on a needs basis, if the person with MS had other 
medical conditions and health concerns requiring medical attention. A study in 
patients with MS in New South Wales confirmed the important role of the family 
physician rafing them as the most important health professional in their ongoing 
management of MS (Black et al., 1994). 
Enteen (1995) showed that the majority (56%) of patient with MS in the USA 
identified their neurologist as the primary care physician. In the USA, the health 
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insurance system means that the medical management of MS does not 
necessarily rely on the general practitioner. However, in Australia, access to 
Medicare means that patients can access all health sen/ices that are 
appropriate without incurring out of pocket expenses. 
However, sen/ices were not 'without cost' to the community, as the payment to 
service providers was through the Medicare levy. The cost of MS to the 
community has been documented in other countries (Canada, United Kingdom, 
United States). In these countries, a large part of the health and social services 
budgets for people with MS comes from revenue drawn from the community 
(Bourdette et al 1993; Whetton-Goldstein et al 1996; Hatch 1996; The 
Canadian Burden of Illness Group 1998). It is highly likely that a similar 
situation exists in Australia, with MS having a considerable economic impact 
on the community, although the investigator is unable to estimate what this 
cost may be. However, by identifying how frequentiy people with MS are 
utilizing Medicare funded facilities, it may help health economic planners to 
spend the health dollar more efficiently for those with MS. 
Pafients with private health insurance or wealth can also access neurologists 
and practitioners who charge for services, at a cost to the consumer. However, 
this has not been documented in the present study, though the comparison of 
such a population with the present study would be informative. 
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Physiotherapy is considered an important part of maintaining potenfial well 
being for a person with MS and is recommended by neurologists. In the present 
study, both males (63.6%) and females (55.2%) were accessing physiotherapy. 
These patients believed that physiotherapy had an important role in the 
management of their MS. This is supported by the research of DiFabio et al 
(1998) which showed that rehabilitafion using regular physiotherapy 
programmes led to significantiy fewer symptoms, preservation of physical and 
cognifive funcfion and improved quality of life. In the current study, employed 
people used physiotherapy less often than the unemployed. This may reflect 
the fact that only the mobile and well MS population remains in the workforce. 
The use of physiotherapy may be perceived by the person with MS, and 
perhaps the carer, as belonging to the more disabled person. 
Access to the physiotherapist increased as disability worsened. Those with an 
EDSS score of 1 - 5.5 (mobile) used physiotherapy less frequently than those 
with an EDSS score of 7.5 - 9 (non-mobile) (44% vs 70% respectively). 
Similarty, as disease durafion increased there was an increase in the use of 
physiotherapy (50% for patients with a disease duration of < 5 years to 68.4% 
for patient with disease duration of > 10 years ). 
Community services were used by a significantly greater percentage of 
unemployed persons (54%) than employed (7%). Most community services 
provided either nursing care or personal attendants for home help on a daily 
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basis, which would not be needed for those who were working or less disabled. 
Another factor in the use of community services is whether the person with MS 
has available family members who take on the carer role and therefore reduce 
the need for assistance from community services. This is not detailed within 
the parameters of this study. 
5.4 Support services 
The Mulfiple Sclerosis Society of Queensland (MSSQ) was used frequently by 
a majority (80%) of persons interviewed, with the remainder not using the 
services at all. All age groups had over 70% usage of the MSSQ. There was 
increased use of MSSQ as disease durafion and EDSS increased, with 100 of 
those who were wheelchair bound accessing MSSQ services compared to 
62.5% of ambulatory people with MS. The wide variety of study participants 
using the services of MSSQ may reflect the diverse support offered for the 
person with MS. The needs of people vary during the course of their MS and 
accordingly, support services of MSSQ are made to meet the broad needs of 
the total population of MS sufferers in Queensland. 
The MSSQ is the specialist support service to address specific needs and 
respite for people in Queensland and northern New South Wales with MS and 
also for their carers. The MSSQ offers accessible and affordable services via 
telephone with a 1800 toll free telephone available to anyone in Queensland. 
Resources and help for specific quality of life issues, such as psychologist 
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support, occupational therapist and home assessment advice, information on 
how to apply for pensions and work intervention counselling are available at an 
affordable cost ($10 a year registrafion). 
The services of the MSSQ appear to play a major role in the care and support 
of people with MS. 
5.5 The use of complementary therapy 
The precise extent of the use of alternative therapies in Australia is yet 
unknown. It appears to be very large, with an estimated one fifth of the 
Australian and United States population visiting alternative practitioners each 
year (Komesaroff et al., 1998). The second hypothesis of this thesis concerned 
the use of complementary therapies by people with MS and the present study 
confirmed that a significant proportion (82.5% or 33 of 40) of participants used 
complementary therapies. 
Previous studies have shown that between 20 - 90% of patients with incurable 
chronic diseases use complementary therapies (Cronan, 1989; Eisenberg et 
al., 1993; Donnelly et al., 1985; Singh et al., 1996; Risberg et al., 1995). ft is 
difficult to speculate with certainty why MS sufferers are in the upper 
percentage of users of complementary therapies. The uncertain course of the 
disease may give more opportunity for hope of control over the disease, or with 
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the disease being one of the younger working age populafion there may be a 
different approach to medical care and self choice for treatment. 
The use of complementary medicines has been detailed in a number of chronic 
debilitafing diseases. In a study of HIV, patients using complementary 
therapies, had a greater sense of control and self management of the disease 
course, but ultimately, the clinical outcome was not impacted by these therapies 
(Singh et al., 1996). The use of complementary therapies by cancer patients 
has also been documented by Risberg et al (1995) who showed 45% of cancer 
patients used such therapies, although it did not influence survival amongst 
these patients. Cronan et al found that as many as 90% of patients with 
musculoskeletal disorders were accessing complementary therapies. Use of 
complementary therapy is also increased in patients with asthma (Donnelly et 
al., 1985) The widespread use of complementary therapies has been 
established by these studies. 
In the current study population, all those who were users of complementary 
therapy were also accessing a conventional medical practitioner, either a 
neurologist or general practitioner. Thus, the fourth hypothesis of this study, 
that people with MS are using complementary therapies as an adjunct therapy 
with mainstream therapies in managing their MS has been found to be correct 
in this population. Donnelly et al documented that 76% of subjects were 
safisfied with both orthodox and alternative medicines and were not disgruntled 
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with orthodox medicine (1985). Eisenberg et al., (1993), in a national survey of 
the use of unconventional medicine in the USA, found that all pafients with a 
primary diagnosis of cancer, if using an alternative therapist, always also saw a 
mainstream medical doctor for this condifion. 
It is now well documented that a substantial number of people with illness will 
access their mainstream medical therapy concurrently with alternative therapies 
(Fawcett et al, 1994). This is confirmed in the present study with 82.5%) of 
patients using complementary therapies alongside mainstream health services. 
The high use of complementary therapies in the mulfiple sclerosis population 
agreed with findings in other chronic incurable diseases of arthritis, HIV and 
cancer. 
5.6 Users of complementary therapies 
Of the 11 males in the study, only 6 (54%) used any form of alternative therapy, 
this is in contrast to 27 of 29 (93.1%) of females (p=0.016). This is an 
interesting observation and may reflect the characteristics of differing 
approaches taken by males and females in managing their own disease and 
their willingness to take 'risks' in self prescribing non proven therapies. It may 
demonstrate that females have a greater need for control over disease 
outcomes. This area would need to be investigated further to determine 
underlying reasons for this occurrence. 
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All subjects in the present study who were aged between 20 - 40 were users of 
one or more complementary therapies, while 6 of 17 (35.3%) persons aged 50 -
59 did not use any therapy at all. This could be explained by the fact that of the 
6 people between the ages of 50 - 59 who were not using complementary 
therapy, 5 (83%) were males. Another possible explanation, is that the older 
generation (50 - 59 year olds) may have a more conservative approach to 
medicine and adhere to mainstream medical advice and let 'the disease take its 
course'. Alternatively, the lack of use of complementary therapies in older 
patients could reflect the stage of the disease. Of the 6 patients in the 50 - 59 
age group who did not use complementary therapies, 2 had SP MS and 3 had 
PP MS. It is possible that those with a progressive form of MS may have a 
different approach to their disease management. 
In this study, 94% of people with RR use complementary therapy compared to 
75% of SP MS and 70% of PP MS as shown in Table 4.15. There was no 
appreciable impact of disease duration or EDSS on use of complementary 
therapies. As the natural course of RR MS is for remissions and relapses, it 
may offer more hope to people with this type of MS to take control of the 'ups 
and downs' of their disease progression, believing that the complementary 
therapy will give some benefits. Except in the very long term, it would be 
difficult to assess (in most RR MS patients) whether a complementary therapy 
was having much of an effect, as the relapse rate is often fairly low (1 - 2 per 
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year) and relapse signs and severity can vary significantly from one relapse to 
another. 
5.7 The cost of complementary therapies 
The third hypothesis addressed cost of complementary therapies. In the 
present study there was a wide range of cost to the consumer of 
complementary therapies, ranging from $0 - $725 per month. This data would 
concur with findings of a New South Wales study of cancer patients by Begbie 
et al (1996) documenfing $0 - $20,000 per year range of cost of complementary 
therapies. Approximately one third (12 of 33) of users spent less than $50 per 
month. Except for the unusual treatments used by one individual, the majority 
of therapies such as acupuncture, vitamins, evening primrose oil and massage 
were relatively inexpensive. For some users of complementary therapy the 
cost was small, vitamins and evening primrose oil costing less than $20 / 
month. The median cost of these therapies was less than $60 per month. 
As discussed earlier, the use of complementary therapies is a common practice 
in chronic diseases, often alongside prescribed mainstream therapies. The use 
of complementary therapies in the United states was over $US10 billion 
(Eisenberg et al 1993), with an estimated expenditure by Australians per year 
of over $AUS1 billion (MacLennan et al 1996). With this amount of money 
spent on unprescribed medications with unknown safety outcomes, health 
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providers and health administrators have a responsibility to monitor and protect 
the public health of its constituents. 
There is often insufficient or negligible scientific information available about 
complementary medicines to allow any sort of "informed decision". Many or 
most of these substances are allowed into the market as "foods" and therefore 
do not have to meet the stringent regulations of drug evaluafion at government 
level. It is for this reason, at least as far as safety is concerned, that adverse 
drug/substance reporting is so essenfial. This of course still does not deal with 
the more difficult area of efficacy of the therapeufic agent. 
5.8 Unmet needs and concerns 
The major concerns raised by people with MS related to activifies of daily living 
(transport, parking), the lack of knowledge about MS within the community 
(both of health providers and community groups), difficulty of knowing which 
services were available for support and how to access appropriate health 
support networks, financial difficulties and constraints for the more disabled 
persons (purchase of pads, catheters), the large burden of care which fell on 
family members (parents, partners and children). These issues should be 
addressed as suggested in the Recommendations Chapter 6. 
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5.9 Summary 
The results of the study indicate that there is a high use of complementary 
therapies amongst people with multiple sclerosis. It is also evident from the 
participants in the present study that complementary therapies are used as an 
adjunct therapy to mainstream medicine. People with MS in this study were all 
using mainstream medicine, had increasing use of physiotherapy and MSSQ as 
disability worsened and were more likely to use community services when 
unemployed. 
For some patients, complementary therapies were consumed or accessed at a 
small monthly economic cost, however, for others the economic impact was 
substanfial. The use of complementary therapies as an adjunct to mainstream 
medicine has been documented in this study, and as Hensley and Gibson 
(1998) have stated: 
"ineffective or unsafe therapies should be abandoned, and unproven 
interventions should be evaluated in high quality clinical trials an 
evidence based approach to health care" 
People with MS are exercising choice and decision making by using 
mainstream and/or complementary medicines. There needs to be an open 
communicafion between the mainstream health professional and the consumer 
so that relevant information about potential adverse reactions can be given. 
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Chapter 6 Recommendations 
0 Medical practitioners and other health professionals should be aware of the 
high use of complementary therapies by people with MS, and document and 
discuss these therapies with patients. 
0 As many patients do not openly discuss complementary therapies with the 
mainstream health provider it is important that patients be asked about the 
use of complementary therapies, so that potential adverse reactions, if 
known, can be discussed and avoided. 
0 Health institutions and government bodies need to make known risks and 
adverse reactions of 'natural' and 'unproven' substances so that an individual 
can make an informed decision about managing his or her disease. 
0 All health professionals and also any prescribers of complementary 
medicines should be aware that any adverse events should be reported to 
ADRAC (Adverse Drug Reactions Committee). This fact should be widely 
promulgated to any potential users of such agents. 
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0 This research has identified that a considerable amount of money is spent on 
complementary therapies by people in the community with mulfiple sclerosis. 
More research is needed to determine effectiveness and side effects of 
these therapies. 
0 Existing mainstream health services provide many services but it appears 
that these may not be utilised to the fullest potential. Access to these 
services appears to be needed at a community level and methods of 
providing accessible health care in the community with intersectorai 
collaboration need to be explored. 
0 For complementary therapies that are demonstrated to be effective and safe 
the quesfion of reimbursement by Medicare Benefits Schedule needs to be 
addressed. 
0 Educafion of health professionals about MS needs to be addressed. MS 
specific courses could be offered in health professional training for General 
Practitioners and other health professionals. One such course for post 
graduate and undergraduate nurses currently exists at the Queensland 
University of Technology. 
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APPENDIX A 
PEOPLE WITH MULTIPLE SCLEROSIS -
MAINSTREAM HEALTH SERVICES AND 
COMPLEMENTARY THERAPIES QUESTIONNAIRE 
Thankyou for participating in this study. As already mentioned, the data collected from this 
study will remain confidential and secure. I appreciate you^time with this project and would 
like you to answer the questions as you feel comfortable. There are some questions that 
require a yes/no answer while others are left open for your comments and answers. 
There are questions about using alternative therapies before you got Multiple Sclerosis. Also 
some questions concerning what therapies were used once you were diagnosed with MS. 
Finally some general information that will help with the general understanding of the 
participants in the questionnaire. 
The aim of the questionnaire is to try and identify what different sorts of alternative (not 
prescibed by your GP or Specialist Doctor) treatments people are trying. This is not research 
into whether these different therapies work, but rather try to find out what diverse treatments 
are used by people with MS and the cost of these medications and treatments. 
Consent to participate in Masters of Public Health Study on: 
*The use of health services / therapies in people with Multiple Sclerosis. 
I , 
understand that participation in the above project is entirely voluntary and all 
infomiation collected will remain confidential. Data will be coded so that my identity 
will not be revealed. 
Signed: Date: 
^tness: 
Health Services Accessed bv People with Multiple Sclerosis 
Code: Date of Interview: ^___ 
NAME: 
DOB: Ethnicity: 
Address: 
Postcode: 
Birthplace: 
Sex: M / F 
Moved <10yrs old?: Y / N 
If yes, to: 
Employment: Y / N Occupation: 
Highest Educational Qualification: 
Comments: 
Medical History 
Year MS diagnosed: 
Initial symptoms: 
Classification of MS: 
1. Relapsing/Remitting 2. Primary Progressive 3. Secondary Progressive 
Comments: 
Current EDSS: 
Other medical conditions: Y / N 
if Yes then list diseases: 
Family History of MS: Y / N 
if yes, then relatives affected: 
Services Accessed: 
• General Practitioners 
Frequency: 
Cost: Nil Cost /$ 
Specialist Physicians 
Frequency: 
Cost: Nil Cost /$ 
Yes/No 
Yes/No 
MS Society 
Frequency: 
Cost: Nil Cost / $ 
Yes/No 
Physiotherapist 
Frequency: 
Cost: Nil Cost / $ 
Yes/No 
Community Health Services 
Frequency: 
Cost: Nil Cost /$ 
Yes/No 
Hospital Outpatient services 
Frequency: 
Cost: Nil Cost /$ 
Yes/No 
• Other: Yes/No 
Have you used any of the following ? : 
• Evening Primrose Oil Yes/No 
• Acupuncture Yes/No 
• Dietary Yes/No 
• Naturopathy Yes/No 
• Vitamin therapy Yes/No 
• Counselling/Psychologist Yes/No 
• Spiritual/Church Yes/No 
• Other: Yes/No 
(Aromatherapy, Chinese Traditional Medicine, Crystal Healing, Herbal, Massage, 
Meditation, etc) 
For each service/therapy accessed or used please detail the following: 
Therapy used: 
• Date commenced (approximate) 
Was this therapy used prior to onset of MS - Yes / No 
Dose and frequency 
• Route 
Cost per unit/visit 
Duration of treatment 
• Beneficial? No Some Moderate Good 
Are there any services for people with MS would you like to see available? 
eg: Medical, social, support groups, transport, access, free/discount catheters 
etc anything you would like! 
What health services for people with MS would you like to see changed? 
What are the major service areas that are of concern to you ? 
Thankyou for your participation with this questionnaire. 
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yJiAyi^A. , 
tain Of Youth? 
osl a step or two? Cant read 
the morning paper as weir' 
Forgot your best (riends phone 
number? Joints stiH and ach-
ing? Any new wrinkled What could be 
the solution to these problems? Pyc-
nogenol (pronounced p//c nah' je no/) 
might be the answer 
Today. Pycnogenol is being used 
against heart disease, circulatory dis-
orders, skin problems, brain dysfunc-
tion, stress, inflammation, sports inju-
ries, hay lever, diabetic [etinopalhy, 
cancer, arthritis and 'M I 
few. y'^^^^^i^ 
These corkfrtiops; ' 
least in part,;by fre^.f 
are free radicail^li'P^^S 
Free radicals "^i 
to name a 
used, at 
But what 
a • Crea: Hesi:.' 
toeffs by dam-
. their.,;n>ap^caJf>ea' The cells 
"* • 1y. f^ *" reproduce. 
get in and waste cant 
cdls steadily decrease in 
causing the tissues to lose 
ndion. This damage acceler-
aging. 
radicals can fuse molecules to-
ether. making the molecules unable 
^ lo function properly. In the skin, this 
uses a loss of elasticity and smooth 
leading to wrinkles. Free radical 
amage is what we recognize as ag-
ng. and I according to Dr. Jeffrey 
Bland, is implicated in more than 60 
diseases. 
By eliminating (breaking down) 
these free radicals, we can assist our 
bodies in returning us to a heattliy 
state, to live longer, happier, pain-free 
lives. We all have free radicals in our 
bodies and we can eliminate them by 
taking antioxidants. 
The accumulation of cholesterol 
(due to the modification or oxidation 
of low density lipoproteins — LDLs) 
can be prevented, or slowed down, by 
antioxidants. 
Pycnogenol is a powerful scaven-
ger of free radicals and an antioxidant. 
II can counteract the effects of aging 
and acts as a protector against today's 
environmenlaJ toxins (such as radia-
tion, pesticides. p>ollution, heavy me-
lals. etc). Made from the bark of pi-
ous marrtlmus (French maritime pine). 
Pycnogenol is pure and natural, hav-
ing no solvent residues or additives. 
Taken orally, it works with vitamin C lo 
enhance vitamin C's activity. 
pycnogenol is not new. In 1535. 
Jacques Cartier (exploring what is 
now Canada) saw many of his crew 
memt)ers die from scurvy. The local 
Indians taught him to prepare a brew 
made from the bark and needles of 
the Ameda pine, which returned the 
men to health. 
400 years later. Prolessor Jacques 
Masquelier discovered that pine bark 
(Pycnogenol's source) contains a spe-
cial class oi water-soluble bioflavo-
noids (proanthocyanidins). These bi-
oflavonoids have powerful antioxidant 
properties and can help rid the body 
of free radicals. 
Pycnogenol inhibits formation of the 
enzymes that cause allergies and in-
flammations, Iheretjy reducing hista-
mine production. For this reason, 
nnany people use Pycnogenol in the 
treatment of allergies. In fact, in Rn-
land. it is popular for use against hay 
fever. 
Pycnogenol is also helpful in im-
proving circulation. When you are in-
jured or have muscle cramps, the 
damaged area needs more oxygen. 
This demand must be met by your 
capillaries, (liny blood vessels which 
brir>g in fresh oxygenated red corpus-
cles and carry away used t)lood). 
To do this rapidly and efficiently, 
your capillaries must be healthy. In the 
case of injury, your capillaries are 
damaged, resulting in swelling and 
bruising. The sooner your capillaries 
return to nornnal. the sooner bruises, 
swellings and pain disappear. Ihe 
sooner you get back into action. Your 
best hope is lo keep your circulatory 
system in as healthy a state as possi-
ble and when an injury occurs, to help 
it respond quickly. 
Helping the lining of arteries resist 
attachment by mutagens (which can 
cause cardiovascular disease), Pyc-
nogenol restores the strength of the 
capillaries and improves circulation., 
making it easier for each .cell lo get 
the nutrients needed. Improved circu-
lation is especially valuable to stroke 
victims, diabetics, arthritics. smokers, 
women taking oral contraceptives arvj 
people with swollen, edematous legs. 
Pycnogenol also has a unique abil-
ity lo bond lo collagen fibers. All cells 
in the human body are glued togeth-
er with collagen. Pycnogenol helps 
these coflagen fibers rebuild their 
crosslinks and reverse some of the 
damage done over the years by inju-
ry and free radical attack. Further. Pyc-
nogenol inhibits the tiody's enzymes 
that break down collagen. Pyc-
nogenol helps return flexibilty lo skin, 
arteries, capillaries, joints arvJ other tis-
sues by restoring collagen. 
The human body cannot survive 
without vitamin C. Pycnoo«rK)l actu-
ally activates vitamin C and helps put 
il to work fast, continuing lo work on 
its own ksng after vitannin C passes out 
of the body. Pycrwgenol vn&s to 
maintain the integrity of blood vessels, 
particutarty the capitlaries. and exerts 
a powerful anti-inflammatory, anti-
infective, antiaging effect. 
Vitamins C and E have long been 
regarded as effective antioxidants. Ac-
cording to Richard Passwaler. Ph.D.. 
in starxjard in vitro studies (test tube. 
The benefits of Pycnogenol 
are many. Pycnogenol has been 
shown to: 
• Retard aging 
• Improve diajlation 
• Improve vision acuity 
• Improve flexitiitty 
• Reduce wrinkfing of the skin 
• Aid in resistance to bnisinQ 
• Reduce mental deterioration 
• Reduce risk of cancer 
• Reduce (isk of heart deseasa 
• Reduce risk of vasoiaf dsease 
• Reduce risk of stroke 
• Reduce risk of phlebitis 
t • Reduce inflanwnatior) in arthritis 
• Reduce inflammaiion in sports injuries 
• Enhance immune resistance 
• Recfcjce frequenc/ and seventy of cdds 
«Enhance faster healing 
• SutxJue aflefgic reactions 
•SutxJuePMS 
• Enhance energy 
• Reduce fatigue 
not in the hum^ntxjdy). Pycnogenot 
proved to be 60 times more powerful 
Ihan vilamin E and 20 limes more 
powerful than vitamin C in the atwliiy 
to scavenge (neutralize) free radicals. 
In addition. Pycnogenol remains in the 
blood stream for 72 hours (unlike vita-
mins E and C which pass quickly 
through the system), thus giving ex-
tended free radical proteciion. 
Studies show that Pycnogenol is 
rapidly absort^ed and distributed 
throughout the body: within 20 
minutes, much of Pycnogenol is ab 
sort>ed and on its way to tissues: with-
in one hour of ingestion, il can be de 
tected in saliva. Because it is acidic. 
Pycnogenot is highly compatible wtth 
human digestion. 
In addition, according to Passwaler. 
Pycnogenol is a nonarrtigenic. non-
mutagenic. norc3rdnogeric and non-
teratogenic substance 
Unlike virtually all other dietary 
products, the beneficial effects of Pyc-
nogenol cross the blood brain barri-
er to protect the tilood vessels in the 
brain from oxidation, thus having 
strong possibilities in fighting senility. 
Pycnogenol has lor^ been used in 
France. Finland. Holland. Germany. 
Italy. Singapore. Korea. Argentina and 
Switzeriand ar>d has just recently 
t)een marketed in the United States. 
In many countries, w^xnen take 
Pycnogenol as an oral cosmetic to 
fight wrinkles before they t>egin. Il 
helps keep their skin elastic, smooih 
and more wrinkle-lree by restoring the 
skin's collagen and protecting it from 
free radical attack and enzymatic 
degradation. 
In today's fast paced, highly stress 
lul, polluted environment, diseases 
from free radical damage are a lact 
of life To combat this damage, free 
radical scavengers are essential. For 
good health, antioxidants such as 
Pycnogenol. vitamins C and E are crit-
ical for daily usage. After all. ".^n 
ounce of prevention is worth a pound 
of cure." 
Dr. Cichoke is a chiropractic physiciai 
in Portland. Oregon and author ol ove 
100 scientiric articles. He is a weii-knowi 
writer lecturer and researcher on healt. 
and nutrition. 
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Xt^ Mutritinnal Benefits of Pycnogenol 
by Dr. AsnoJd Pike, Director 
A.ciidemy of 2^utiidonaJ Sciences 
Pycnogenol is ihc uadc name for a new jxjicnt antioxidant nutrient that comes from the bioflavonoid 
family of compounds, l l can be extracted from grapes, cranberries, beans and other fruits and vegetables 
but its richest souire is from the French Maritime Pine Tree. Tbc discovery of Pycnogenol, perhaps 
accidcnul, can be traced lo a French explorer over four hundred years ago. 
!l dates ^ack to 1535 when French explorer Jacques Canicr, on his 2nd voyage of exploration lo 
Canada attempted to sail up what is now known as the St, Lawrence River in Canada. But, this was a 
trip he would not soon forget. Il was winter and Canicr and his men were caught in the firigid snows 
of Quebec. 
Explorer Cartier and his crew tried to sunrive on biscuits and salted meat, but lacking fresh fruits and 
vegetables Ihcy became viciims of the dreaded disease scurvy. Their teeth fell out, some even lacked the 
sucnglh to walk. About 25 perished before friendly Quebec Indians came to their rescue. The Indians 
were knowledgeable about the healing properties of trees and herbs and ihcy prepared a lea derived 
from the needles and the bark of specific pine trees native to the area. Canicr and his men drank the tea 
and applied the precipitate as a pouliicc. Within days the remainder of ihc crew were up and about, 
their gums Slopped bleeding and their strength returned.The tree bark proved remarkably efTcciivc. Of 
course, no one back then knew that pine needles contained vitamin 'C and that the bark provided an 
abundance of flavonoids which enhance the body's utilization of vilamin 'C. 
Fonunaiely, Canicr documented ihe pine tree mcidenlin his travd log "Voya^ Au Canada". Then 
more than 400 years later French professor Jacques Masquelier, on assignment at the Universiiy of 
Quebec, read Carticr's book and was parlicuJaxly inuigued by his documcntatioo on how the pine tree 
saved his expedition from being destroyed by scurvy. At ihis time Masquelier T^ SS deeply involved in 
his own research on bioflavonoids. He suspected, from Cariicr'j wxitings, that this particular tree must 
be rich in bioflavonoids. Following considerable testing. Professor Masqudicr isolated the active 
components in samples of bark from this unique pine tree These samples came from the St Lawrence 
River area. Upon reluming to France, he discovered that the richest source of this highly bioactive 
substance, called proanthocyanidins (or procyanidios \ Pycnogenol's active ingredient, woe found in 
heavy concenirations in Ihc bark of Ihc French MaritiiK Pine (Pinus Maritima). This tree is found in 
abundance in the huge Les Landes pine forest in southern France. The extensive research by Professor 
Masquelier, that led to the discovery of Pycnogenol, was suppoiicd and financed by Mr. Quuics 
Hairaorr, founder ofHorphag Research Ltd. 
In October 1992,1 met with Mr. Nick A. Mangcrls in wuthcm France. V/i> cojoyed a tour of ibo Lc9 
Landes Forest, viewed local saw mUls where the bark of the Maritime Pine was being removed and ihcn 
BOWEN TECHNIQUE 
T(^ 7S mcredMe tecfmioMe is currently being lawglji anb pactised n/orfo 
wibtf mil) remarkMe success. T(;e late Mr Dom Bourn's sy)stem is a 
unique lljeraf^ li^cl^ involves a gentie^ b^namic system of muscle 
anb connective tissue moves wijid) realign ti^e bob-^ anb balance anb 
stimulate tS^e energy flow^ empoyverinQ t\)e bob^'s own resources to h^l 
Ttseff. 
Patients report "feeling t(;e energy release anb HoWj anb a state of beep 
relaxation. Treatments are ibeall^ bone on soft^ low treatment tables 
anb moves are effective ti^rougl^ clotl^inQ, Sessions can last from lO to 
40 minutes. Relief is often att^ine5 <;ifter t^e first session^ anb some 
clients onl-^ neeb two or tlnree treatments^ usually one week ajjart 
Conditions are treated l^olisticall^ not specificali;(}^ yet tijere are few 
conditions M i^dj; cannot be adbresseb [witlf tl)e approjjriate mebical co-
oj)eration). It stimulates circulation^ encourages lymphatic anb venous 
brainage^ promotes a^ssimifation of toDcins, increases joint mobility anb 
improves posture. "Excellent results are reported from t(w)se wrtl; 
sprtin^ injuries^ back adjes anb pains^ joint biscomfort^ bronof)ialf . 
urinary anb female problems. 
Many [icensed l)ealti) care poctitioners arounb tl^e worlb are now 
using t{;e tecljnio^e anb are full of praise for the amazing results. 
BoM n^'s 0ift was biscovering xi)e bynamic sj^ stem of moves t\)at 
reinst<^ te natural flow^ restorinjg the structural anb therefore t(?e 
functional integrity of t(;e boby^ anb t(ms peeping nature in 
balance. T^e key to tf;e XjeAjniofue's success is its (;o(i5tic action 
This is a concept of energy, bodywork, and a composite 
healing philosophy based on East Indian Ayurvedic 
principles. Created by Dr. Randolph Stone, an osteopath, 
chiropractor, and naturopath, polarity is designed to 
balance the body's subtle or electromagnetic energy. 
The main techniques used are touch, working with 
polariti; trigger points, stretching exercises called 
'polariti; yoga' or 'polar energetics', an approach to 
eating and nutrition based on the philosopher's 
principles, and attitude and mental-emotional 
balancing. 
Unlike other bodywork techniques. Polarity Therapy does not 
manipulate muscles or bones but works through the body's own 
energy system by placing hands on the body's energy centres to 
redirect the flow* Polarity therapists see the body as a core 
magnet that generates an energy field around it. When the 
energy currents are blocked or impaired, the physical, mental, 
emotional, and energetic levels of the body lack the balance and 
strength to nourish the whole being and stress, pain and illness 
can result. 
• ' - / 
Energi; maniputan6WDyTou^ the main technique, 
however it's not the only focus. Adjustments made in 
the current flow will not last if poor habits are maintained 
- in nutrition, exercise, and thought. Exercise is part of the 
total approach. 
This technique ^vas developed by the American chiropractor, 
Dr George Goodheart. Derived from the Greek word kinesis 
which means 'motion', it combines muscle-testing with the 
ancient principles of Traditional Chinese Medicine to diagnose 
the energy levels of the individual and where the energy is 
being blocked. 
The technique itself employs a range of gentle yet powerful 
natural healing techniques to improve health and increase 
vitality. Kinesiology can address any number of symptoms 
because it balances the whole body and puts it in the most 
optimum state to heal itself. 
Kinesiology is useful for a variety 
of disorders, from headaches to PMS. 
It is a relaxing and effective system 
to help achieve wellbeing. 
THE DEVELOPMENT OF OXICHEL^ 
by Dr WD Raymont, Ph.D., M.A.C.S.. .VI..N.Y.A.S., D.G., O.IA. 
TTM is an infoimalicin shea prepared £.\Ehiaveiy for HeaJth Profssionsls who are exempted from Ihe restrictions of Part 2 - .Advertisements of the Therapeutic 
Goods Regulations under the Therapeutic Goods Aa. 1989. Supply of this infonrtauon to other than Health Professionals as defined m that Part of the 
Regulaiions may constittue an offences Health Professionals: 
'4 (1 X») medicaJ prauxuuav psychologias. demids. vooinary surgeons^  pharmacists, physiotherapists, dietitians, scientists working in medical 
laboratories or nurses; or... 
(c) hotialists. homeopalhic praomcxiers. chiropractors, naturopaths, .nutritionists, practitioners of traditional Chinese medicine 
or osteopaths registered under a law of a State or Temiory... 
(2)... penons who ire membet3 of an Australian branch (however described^ of one of the bodies referred to in Schedule I. 
(2A) -. a pawn... (who) has the qualifications and tninmg that are necessar>- or appropriate for membership of the (subregulalion (2)) 
relevant body." 
OXICHEL' is a highly developed and powertul antioxidant, 
vitamin, mineral and herbal dietary supplement with a total 
of 32 ingredients. This product is patented and is licensed 
exclusively to Herbal Dvnamics on a world-wide basis. 
VITA>nNS: 
The vitamins and minerals in OXICHEL" have been selected 
to provide the most advantageous combination and quantity 
of each restricted only by some national (Australia and New 
Zealand) Regulations. Particular attention has been given 
to the NH&MRC RDI of each and particular emphasis has 
been placed upon recognised international research 
published in recognised scientinc and medical joumais. 
Reductioo of Cancer Ruiu 
Recently completed long-term studies have shovvn the 
antioxidant vitamins A C, E and Beta-Carotene (Provitamin 
A) to have significant effects in reducing the incidence of 
cancer. 
A major study was conducted over a period of five years on 
30,000 residents of the Linxian region of Northern China 
where stomach and oesophageal cancers are 100 times 
more common than in the USA. The results of this study 
were published in the Joumal of the National Cancer 
Institute. The 15.000 residents who were given a cocktail 
of Beta-Carotene, Vitamin E and Selenium (Selenium is a 
Schedule 4 prescription drug in Australia) showed a 
reduction in cancer-related deaths of 13%, a reduction of 
9% in overall deaths and a 21% reduction is stomach and 
oesophageal cancer. 
la Finland, Or Jussi Huttunen, the Director of the National 
Public Health Institute, released the results of a study on 
29,0(X) smokers who were given a daily supplement of 
20mg Beta-Carotene and 50ing Vitamin E. These results 
have been published in the New England Journal of 
Medicine and show a substantial reduction in lung cancer. 
Dr Gladys Brock of the University of California in Berkeley 
researched 170 scientific dissertahons on vitamins and 
'^^ortedthat 132 of them attrstrd to the efficacy of vitamins 
against cancer. Professor Jurgen Wahrendorf of the 
Gennan Cancer Research Centre in Heidelberg reported 
thai Dr Brock's research demonstrated reducaons in cancer 
nsks by up to one half." 
An eight year study of 90,000 nurses by researchers at 
Harvard University in Boston showed that nurses with a 
die:ar>' deficiency of vitamin A suffered a 20% higher 
incidence of breast cancer. 
Currendy, worldwide, there are over thirty long-term studies 
of the anti-cancer effects of vitamins unden.vay and one of 
the greatest advocates of antioxidant vitamin 
supplementation would be 93 year old Nobel Laureate 
Professor Linus Pauling. 
Chelation of Cholesterol Plaque From Arteries 
The relationship between trace residues of the heavy metal, 
cadmium, and artenal deposition of cholesterol is well 
documented and was first proposed in the 1960's by 
Professor Harry Bloom of the University of Tasmania. 
Extensive research b}c WHO in the late 1970's, in which the 
writer took part, confirmed this relation^p beyond any 
reasonable doubt 
Considerable success in the chelation of the cadmium metal 
firom this cholesterol plaque, thereby re-dissolving the 
cholesterol, has been reponed from regular massive 
intravenous inlvisions of EDTA and/or vitamin C but 
clearlv, less invasive methods would be much more 
desirable. 
Over recent years, more and more evidence is coming to 
light that the antioxidant vitamins can fulfill this role to a 
greater or lesser extent. Not only have they been shown to 
have efficacy in the chelation above, but also in the 
inhibition of LDL oxidation. 
Certainly, the presence of fi'ee radicals has been well 
accepted as the cause of much caniiovascular disease, 
especially atherosclerosis. Equally well accepted is the role 
of antioxidants in combatting free radicals and thereby 
preventing, controlling or even reversing such disease. 
Antioxidant vitamins also have reported efficacy in the 
reduction of h3rpertension. 
Fur ther reading 
Perhaps one of the best and most comprehensive reviews of 
the function and health effects of vitamins in recent years is 
Pagel 
in the .Vnnals of the New York Academy of Sciences. 
Volume 669. entitled Beyond Deficiency (ISBN 0-89766-
750-6, SUS125.0O) with five papers each on the 
Cardiovascular and anti-cancer benefits of vitamins (with 
33" and 279 references respectively). 
HERBAL AiNTIOXTDAiNTS: 
Some of the most significant advances in recent years have 
been in the field of herbal antioxidants. One propnetary 
product receiving much publicity at the moment is 
Pycnogenol*, the Registered Trademark of Horphag 
Pharmaceuucals of Guernsey, U.K. This pnxluct is a 
proanthocyanidin concentrate; proanthocyanidins are 
someomes referred to as leucocyanidins, bioflavonoids and 
pohirers of catechm. 
Proaathocyanidins are narjrally occurring antioxidants 
which are claimed to be up to lifty times more powerful than 
the anuo.xidant vitamins and to have much more effective 
bio-uptake. The major disadvantage of concentrates of 
these substances is the prohibitive cost - up to SUS3.70O 
per kilogram! 
However, cost has had to become a secondary factor in the 
formuiaaon of OXICHEL* as, with its formulation, a 
commitment was made to produce the best and most 
effective antioxidant combination practicable and, as a 
result, proanthocyanidin concentrates represent some forty 
milligrams of the formulation of each tablet. Concentrated 
extrxcs from red grape seed, bilberry frtiit and lime flower 
have been formulated to provide the maximum quantity and 
bio-availabihty commercially feasible along with twenty-
five milligrams of bioflavonoids in each tablet 
Ginkgo extract has been included to potentiate the 
absorption of the proanthoc/anidins and leucanthocyanidins 
and because of its documentation in herbal medical texts as 
a circulatory system stimulant 
Echinacea extract is similarly well documented as an 
immunostimulant, anti-inflammatory and antibacterial. 
The therapeutic claims for garlic need no re-iteration and 
paniey has been included to contain the odour of the garhc. 
MINERALS: 
Nine essential dietary minerals have been included to 
supplement normal dietary intake but sodium and 
phosphorus have been avoided as both of these are present 
in excess in normal diets. Furthermore, selenium has also 
been avoided as this is a prescription drug in Australia. 
DOSAGE: 
One or more tablets twice daily depending upon age and 
state of health. Therapeutic doses of three tablets three 
times per day can be directed by health care professionals. 
TGA: 
OXICHEL* is listed on the AustraUan Register of 
Therapeutic Goods as a non-prescription phannaceuticai 
product (AUST L54069). 
EACH TABLET CONTAINS: 
aET.A.C.\ROTENE 2.0mg 
THLAMINE HYDROCHLORIDE (VITAMIN B1) 500ng 
RIBOFLAVTNE (VTTAMIN B2) gOOMg 
NICOTTNAMIDE 23mg 
CALCILM PAiNTOTHENATE (VFTAiMIN 85) 50mg 
P\1UDO.\INE HYDROCHLORIDE (VITAiVirN B6) l.Omg 
CY.A.\OC08AI^VlIN (VrfAMffTB+il l.OMg 
ASCORBIC .ACID (VTTAiVUN Q 200mg 
CHOLECALCIFEROL (VIT.AMIN D3) 6.1 ug 
D-.ALPH-A-TOCOPHEROL (\Tr.AMIN E) 2Img 
BtOTIN 30ug 
FOUC .ACID 73ng 
CALCILM {AS AMINO ACID CHELATE) lOmg 
CHROMn^M (AS CHROMIC CHLORIDE) lOMg 
COPPER {AS GLUCONATE) 10MS 
IODINE (.AS POTA5SIL^ SALT) 1 S^g 
IRON (.AS .AMINO ACID CHEL.ATE) 2.6mg 
MAGNESIUM (AS AMINO ACID CHELATE) 5mg 
.MA.NGANESE (AS AMINO .ACID CHELATE) 1 .Omg 
POT.ASSIUM (AS GLUCONATE) lOmg 
ZINC (.AS AMINO .ACID CHELATE) I.6mg 
BIOFL.AVONOrDS 25mg 
CHOLINE BITARTR.ATE 25mg 
CYSTEINE HYDROCHLORIDE 50mg 
INOSITOL 25ing 
yiTSS VI^flFERA (GRAPE) SEED EXTRACT 
EQUTV DRY SEED l.Sg 
P£r?,OSEIJSUM aUSPU^i ( P . A R S L E Y ) 
HERB DRY 30mg 
ALLJVMSATIVUM (OARUC) EXTRACT 
EQUrVBlABDRY 35mg 
f^CC3y/LW.WTO711Z.C/5 (BILBERRY) EXTRACT 
EQLTV FRLTT DRY 500mg 
ECHiyACEAfPURPURAE {ZCmSACZA) EXTRACT 
EQUrV ROOT DRY lOOmg 
TIUA CORDATA (UME) EXTRACT 
EQinV F L O W E R DRY 70mg 
GD'^TCCO BLLOBA (GINKGO) EXTRACT 
EQUIV LEAF DRY 60tng 
TABLETTING AIDS (NZ) 
Also contains suortue as an excipient in proprietary ingredients (less than 
Smg per tablet) 
Contains no added artiflcial colonn, OaTonn, sweetenen or 
preservatives and no ghiteii, yeast, rice, wheat or com. 
CONCLUSION: 
OXJCHEL* provides the user with the most comprehensive 
and synergistically formulated antioxidant, vitamin, mineral 
and herbal dietary supplement possible at a realistically 
affordable price. 
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A ViMStepT^ardsBecomi^ 
Toxins 
Leslie Kenton, in her popular little book, 
"The 10 Day Clcan-up Plan" wrote that, 
"beautiful skin, a firm and healthy body 
and a clear mind arc strongly dependent on 
your system being able efficiently and 
effectively to get rid of toxic materials and 
the waste products of your bodily 
metabolism before they have the chance to 
do damage to cells and tissues, organs and 
systems. This principle forms the 
foundation of the long European tradition 
of natural medicine: Remove whatever 
obstructions to rapid and near-complete 
elimination there may be present in the 
body. Then, thanks to the natural laws of 
self-healing by which living organisms 
appear to be constituted, bodily functions 
will tend to return to normal." 
"...The human body is magnificently 
designed to cleanse itself automatically 
without any thought ever needing to be 
given to the process. The trouble is that 
the kind of food and drink most people in 
the West put into their bodies, the tendency 
we have to lead stressful but sedentary 
lives, and the increasing number of 
pollutants to which we arc exposed 
through the air we breathe and the water 
we drink have created a situation in which 
often far more toxins arc taken into the 
body, and far more metabolic wastes 
produced by it, than we can effectively get 
rid of They are stored in the tissues where 
they lower vitality, encourage the 
development of degenerative diseases and 
eariy ageing, and rob your system of 
nutrients necessary to keep your skin and 
hair - indeed, your whole body - looking 
their best." 
"Dr Dwight McKec, Medical Director of 
the International Health Institute in the 
United States believes, as do a growing 
number of doctors ... that our cells arc 
literally chock-full of metabolic and 
environmental wastes gathered over a 
lifetime. To live at a high level of health 
and vitality and to make the most of our 
potential for good looks we need to get rid 
of them." 
The Effed of Toxins 
Toxic accumulations in the body create an 
environment in which it becomes easier for 
disease to develop. As toxins increase 
within the body, proper oxidation cannot 
take place in the tissues and the body is 
unable to properly replenish its cellular 
structure and the excretory organs such as 
the skin, liver, kidneys, lungs and 
lymphatic system arc unable to cope with 
the increased workload being placed upon 
them. The functioning of these organs 
becomes erratic and unreliable. Cellular 
metabolism becomes sluggish, repair and 
growth arc delayed and the ability to 
eliminate waste is lowered. Cells within 
the body begin to die or become inactive. 
Even though we are not feeling our 
best, it is a good sign ... we know 
that somewhere inside restoration 
has begun and soon we will be the 
healthier for It... 
What is "Detoxing"? 
Detoxing has been described as the body's 
"Spring-cleaning". For example, certain 
herbs and other foods can bring about a 
natural cleansing inside the body which 
allows the body to take in fresh nutrients 
and to revitalize itself As this happens 
toxins which have accumulated, perhaps 
over many years, begin to be released. 
Sometimes as this happens, the body 
experiences symptoms such as headaches, 
tiredness, bad breath or body odour, 
swelling in the body, slight skin irritations, 
aches and pains in joints and body, or 
perhaps slight nausea. We might even 
imagine that whatever we have taken has 
actually made us sick 
But this is almost always a good sign: 
somewhere inside us something is finally 
happening which will help us and 
eventually bring about a restoration. 
Usually, such discomfort will only be 
minor, lasting only a few days at most, and 
will not greatly interfere with our daily 
routine. However, some folk with 
particular medical problems may 
experience quite severe headaches and 
other reactions as their bodies undergo a 
cleansing. 
In her book "The Biogenic Diet", Leslie 
Kenton writes, "Very occasionally when 
someone goes on an active programme of 
detoxification such as the biogenic diet or -
even more so - the applefast, he or she has 
the experience of a severe headache at 
some time within the fust three days or of 
feeling moody or of having an upset 
stomach or loose bowels. This is a sign 
that your body is throwing off wastes at 
such a pace that you are experiencing what 
is known in natural medicine as a 
"cleansing crisis". In fact it happens to 
very few pteople. If you are one of them be 
glad - even though it may be a bit of a 
nuisance for a few hours, it is actually a 
good sign. Your body is taking the 
opportunity you have afforded it through 
what you are eating (and what you are not 
eating) to throw off a lot of debris which 
you need to get rid of if you are to shed 
unwanted fat permanently and live at a 
higher level of health and vitality." 
"People most likely to get a headache as 
part of a cleansing crisis are those who 
have been drinking several cups of coffee 
a day. This kind of reaction is triggered by 
your tissues dumping a lot of stored 
caffeine into your bloodstream all at once 
in order to eliminate it from your body." 
Our own research is showing that some 
people who have conunenced taking 
Herbal Dynamics' powerful new 
antioxidant product OXICHEL" (AUST L 
54069) arc experiencing this type of 
"detox", as the combination of herbs and 
proanthocyanidins in the product appears 
to be far more effective in ridding the body 
of toxins and free-radicals than products 
they previously were taking. Many, having 
continued with the product, also have 
commented on the additional energy that 
has followed. 
Antioxidants Help 
Leslie Kenton writes, "Antioxidants are 
nutrients - such as vitamins A, C, E, some 
of the B complex, beta-carotene, zinc, 
selenium and some of the sulphur-based 
amino acids - which help protect living 
systems from the free-radical damage that 
occurs when the body has a high burden of 
toxicity or is exposed to radiation. 
Free-radicals are formed in your body in a 
variety of ways. Some arc simply by-
products of normal metabolic processes. 
Others come as a result of radiation 
damage arising, for instance, through 
exposure to the hazards of low-level 
nuclear radiation in the environment or 
electromagnetic emanations from 
equipment such as video-display units of 
computers or even the ultraviolet rays of 
the sun. Still others are created through 
the process of peroxidation whereby the 
fats or lipids in your body react to fomi 
chemical compounds known as peroxides. 
Whatever their origin, free-radicals create 
toxicity in the system - toxicity which can 
encourage the laying-down of fat-stores, 
damage to cells and cell parts, lowering of 
vitality, cellular pollution, and interference 
with the healthy metabolic functions which 
make high-level well-being possible. 
Antioxidant nutrients, as noted, help 
protect your body from free-radical 
damage. They are master detoxificrs. 
Each antioxidant has a specific action on 
your body. For instance the water-soluble 
nutrients such as Vitamin C help protect 
your body's water-soluble molecules while 
the oil-based cell membranes in the body 
get better protection from a fat-soluble 
antioxidant such as Vitamin E. 
But these antioxidants - which you take in 
through the foods you eat and which are 
also available in higher levels in the form 
of nutritional supplements - all work in 
synergy. That is, they work together, with 
the actions of each supporting the actions 
of many others. And it is the multiple 
interactions of nutrients - never their single 
actions - which make them biologically 
efficient in detoxifying your body and in 
restoring normal metabolism." 
And this is why we believe that broad 
spectnim, synergistically balanced products 
like OXICHEL* will give better results than 
the individual ingredients taken as separate 
supplements. OXICHEL* also includes 
proanthocyanidins from at least four 
different sources, greatly increasing its 
potential in countering the effect of free-
radicals. 
Leslie Kenton continues, "Taken three 
times a day with meals for a few months, 
a good nutritional formulation of 
antioxidants together with a fiiU range of 
other vitamins and minerals with which 
they work may be of real help to [many 
people]. It can hasten the detoxification 
process of the body. It may also speed the 
process of restoring nutritional support to 
the metabolic machinery so that it starts 
working at peak ..." (Pages 97 & 98, 77ic 
Biogenic Diet) 
What can we do to help? 
To encourage elimination, there are two 
areas where we can do more to assist: 
The kidneys: 
To help the kidneys it has been suggested 
that one could drink a litre of parsley tea 
each day. One "recipe" is as follows: 
Parsley Tea 
Place a bunch of paniey in 1 litre of water. 
Bring to boiL When boiling turn stove off 
Let stand for 10 minutes. Strain. Drink tea 
during the d»y; either wann or cold. 
The bowel: 
To help the bowel cope with the extra 
waste being produced take one tablespoon 
of Milk of Magnesium (available at most 
health food stores) every hour until your 
bowel movements are diarrhoea. Then cut 
back to one tablespoon three times a day, 
or until you find what suits your body. 
Other ideas... 
For headaches: 
Milk of Magnesium will also help with 
headaches. 
For joint aches and pains: 
First thing in the morning before anything 
else, have a glass of warm water with half 
a lemon squeezed into it 
For sidn irritations: 
Make a cup of camomile tea, let it cool, 
then bathe the area affected using cotton 
wool (or similar) to spread the tea. 
Remember... 
Sickness and disease do not usually happen 
overnight but are the result of possibly 
years of wear and tear upon our bodies. 
Nor can they usually be corrected 
overnight or even within a few days. But 
entering a period of "detox" is a guarantee 
that our bodies are busy repairing and 
restoring. 
The Lymphatic System 
"There are five main eliminative routes in 
your body - the skin, the lungs, the kidneys, 
the bowels and the lymphatic systan. 
None of them is less generally recognized or 
more important in spnng-cleaning the body 
than the lymphatic system. Yet the state of 
Its health and Ainctioning is still almost 
completely ignored by most people. Your 
lymphatic system is not only a major route 
for the absorption of nutrients from the 
digestive system into the tissues - which 
helps keep skin healthy, youthful and 
glowing - and an important carrier of 
immune cells which guards your body from 
damage and illness and prevents 
degenerative ageing, it is also your body's 
metabolic waste disposal system. Canying 
unwanted proteins and large particles of 
waste maUer which caruiot be removed by 
any other means away from your cells and 
tissues, it clears away toxins - the by-
pnxkicts of fatigue and of stress, dead cells, 
fatty globules, pathogenic bacteria, heavy 
metals, infectious viruses and other assorted 
debris which your cells cast off. So 
essential are the waste-eliminating functions 
of the lymphatic system that without them 
you would die within 24 hours." Leslie 
Kenton, The 10 Day Clean-up Plan. 
Anyone wishing to read fiirther on this 
subject is encouraged to read L.eslie 
Kenton's books, "The 10 Day Clean-up 
Plan - Detoxify Your Body for Natural 
Health and Vitality" (Century Hutchinson 
Ltd, London, 1986, ISBN 0 7126 1029 4) 
and "The Biogenic Diet - The Natural Way 
to Permanent Fat-Losf^ (Arrow Books, 
Londoa 1986, ISBN 0 09 950740 4). 
The Natural Remedies Infonnation 
Group 
We are a voluntary group dedicated to 
ii^ jivvfljgoQe another's quality of life. We 
have no joining fees or subscriptions and no 
affilialian with unprincipled maileling 
gurus. W« hold regular meetings io keep 
our membos and other interested persons 
up to date wit& anecdotal. a> weO as 
fechnicat and research, malenaL 
Ifwe can help fiirtfa«r in any way, please do 
not hesitate to contact one of the fbfiowing 
members or the person who gave you this 
sheet. 
lindttAsh (07)3278 7015 
Bevan Collingwood (071)232181 
RusseUWade (071)222997 
iMsebtroeK This infonaatkio is not 
JdeadedtD nsplttco quali&d tBcdica] advice 
bot is pte&enieti in good faith for 
educational purposes only. If in doubi, 
ptease seel: appropriate mfidtcal advice^  
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Guest Editorial 
Evening 
Primrose Oil 
Can Therapeutic Claims 
be Justified? 
PJ. Scott 
Department of Medicme, 
University of Auckland School 
of Medicine, Auckland 
Things were much easier for William Withering 
studying the foxglove in the late eighteenth century 
than they are for today's medical practitioners and 
clinical scientists investigating the virtues of the an-
cient general panacea, 'King's cure-all', Oenothera 
biennis, or evening primrose. Withering had a single 
sotirce for his basic information, the media did not 
exist in their modem form, and he did not have to 
concern himself with the properties of individual gly-
cosides versus the effects of the gypsy's infusion. Some 
things have not changed since the eighteenth century, 
however, notably the human propensity for supersti-
tion and belief in magical practice, and the concom-
itant distrust of the scientific method with its slow-
ness in terms of unravelling the mysteries of chronic 
diseases. Moreover, there is an evocative, glamorous 
and soothing overtone to the name 'evening primrose 
oil', and even the chief constituent of interest, gam-
malinolenic acid (GLA), has an impressive title. 
Gammalinolenic Acid and 
Fatty Acid Metabolism 
The starting point for resurgence of medical inter-
est in evening primrose lies in theoretical biochem-
istry. Abnormalities of essential fatty acids (EFA) in-
take and absorption are extremely rare despite the 
diversity of htmian diets, but there has been evidence 
for some time that aberrations of essential fatty acid 
pathways might underlie a nimiber of metabolic dis-
turbances in a series of chronic diseases. 
Life as we know it depends upon membranes which 
provide the basis for spatial ordering and thus for 
chronological sequencing of chemical events. Essen-
tial fatty acid metabolism must function efficiently in 
order to preserve the balance of essential lipid com-
ponents in outer cell membranes and intracellular 
membranous structures. Abnormalities of essential 
fatty acid metabolism are demonstrable upon a gen-
etic basis, e.g. in atopy, and they also appear as sec-
ondary phenomena, e.g. in diabetes or alcoholism. It 
is possible that the effects of ageing and of altered 
balances between dietary constituents may affect the 
relative levels of activity along the essential fatty acid 
pathways [1,2]. All essential fatty acids are polyun-
saturated and their metaboUsm follows one of 2 path-
ways (fig. 1). The so-called n-3 pathway derives from 
the biologically inactive precursor alphalinolenic acid, 
the n-3 notation being derived from the position of 
the first double bond firom the omega end of the fatty 
chain. The evening primrose oil story is concerned 
with the n-6 pathway which starts with cis-linoleic 
acid. 
Prostaglandins and leukotrienes are the technical 
terms applied to some short-Uved, highly reactive mo-
lecules which derive from these 2 metaboUc path-
ways. The PGj series of prostaglandins, produced by 
the n-6 pathway, dilate blood vessels, and inhibit both 
inflammatory reactions and platelet aggregation. More 
peripherally along the n-6 pathway, however, one 
branch of the sequence leads to production of leu-
kotrienes which stimulate infiammation and cause 
smooth muscle spasm. At this end of the pathway 
thromboxane A2 is produced and this molecule also 
induces vascular spasm, thrombosis and inflamma-
tion of blood vessel walls. The relationship of leu-
kotriene metabolism to obstructive airways, disease is 
[Illustration prepared by ADIS Press.] 
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thromboxane derived from endogenous arachidonic 
acid, can be explained as a result in a fall in cyclic 
AMP resulting firom reduced production of FOB, from 
dihomogammalinolenic acid. In the presence of cycUc 
AMP, there is inhibition of mobilisation of arachi-
donic acid from phosphoHpid stores [4]. To date, no 
trials of gammalinolenic acid in diabetes have been 
reported. 
Evening Primrose Oil in Perspective 
There is a small but increasingly impressive set of 
pubUcations on essential fatty acid metabolism which 
is consonant with the basic theory proposed by Hor-
robin and others, and there is sufficient experience 
with preparations such as 'Efamol' to indicate that 
consumption is probably harmless, particularly while 
the cost remains high and gross overconsumption is 
therefore unlikely! Others beside William Withering 
have provided historical precedents demonstrating 
that significant therapeutic advances can precede 
understanding of intermediary raetaboUsm. Ethically 
motivated optimists amongst the ranks of medical 
practitioners, who link this historical fact to the 'first 
do no harm' precept, can produce a case for coun-
selling patients to try gammalinolenic acid for man-
agement of various chronic conditions for which or-
thodox medicine lacks any efTective remedy. 
Practitioners who favour such a philosophy should 
advise patients not to consume vast quantities of any 
polyunsaturated fatty acid preparation such as 'Efa-
mol', because there are theoretical reasons why high 
levels of consumption might, paradoxically, acceler-
ate ageing or even be carcinogenic. These are areas of 
ignorance and counsels of moderation should prevail. 
Another group of practitioners can, for equally valid 
philosophical reasons, point to the vast numbers of 
therapies which have had a seemingly rational basis 
but which have fallen by the Avayside. These doctors 
may prefer to counsel their i}atients to save dollars 
and cents, to follow the New ^ Zealand nutritional 
guidelines, and thus to consume a wide variety of 
foodstuffs in amounts which do not upset energy bal-
ance. In any event, advice should be tailored to the 
patient and his or her family circumstances, with due 
regard to psychosocial factors and the usefulness or 
otherwise of the placebo effect [22]. Whatever the out-
come 20 years from now, the work stimulated by Dr 
Horrobin and others will be seen as a major contri-
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APPENDIX C 
Concerns of people with MS 
Subject (1-40) concerns made in open ended questions: 
1. Transport difficult to find parking spots, Carers Network to support each 
other, home access and preparation for worsening disability in future, cost of 
living generally very high for pensioner, MSSQ very helpful and supportive, 
medical tests too expensive and no monetary return for MRI 
2. Need free medical equipment eg catheters etc as the allowance is not 
enough for the whole year. 
3. Wants refund on Naturopathy and other complementary medicines refund on 
MRI when diagnosed, would like more information on complementary 
therapies 
4. More counselling sen/ices should be available at any time of the day or night 
5. Very content with services really nothing else they want 
6. Would like case managers to have holistic approach, assistance with 
shopping friend to help with the chores. More cohesive programme to link all 
services. Complementary services should have obligation to clients for 
linking with other medical practitioners and should not lead to dependency 
on a particular treatment regime. She is 'cynical, angry and broke'. 
7. Local doctors should be better educated about MS as they know very little. 
More public awareness about MS as people don't understand about the 
tiredness. Also dislikes the comparisons everyone makes between people 
with MS. 'We are all different'. Would like to get information in a more 
positive environment. More and easier access for people with ms and 
transportation - roads, ramps and parking 
8. Feels that the services have improved and that there is more offering than 
before for people with MS. 
9. Content with everything as it is 
10. Would like access to physiotherapists within the home community rather 
than having to access the MSSQ physio - too far Would like home help and 
transport assistance more parking and people to assist in shopping. Would 
like more awareness of the disease amongst health professionals especially 
GPs and physiotherapists. Need more carer support networks and need a 
geographically separate place from the mssq as it scares some people. 
Maybe in community health centres. 
11. Someone to write cheques and lists for her and also the continuing cost of 
maintaining the scooter someone to pay for repairs. Need wheelchair for 
outings with friends. 
12. Content with the services available. 
13. Family does not want to know about the disease and this leaves her isolated 
and feeling that she is faking the disease. Not even husband, mother in law 
is sympathetic 
14. Need advice prior to purchasing equipment as expensive and difficult to 
procure. Government refuses to assist if have assets. Community nurses 
wonderful. Feels MSSQ does not want people to come if they have money 
to access private help. If waiting in hospitals should have better facilities 
while waiting to see health providers. Would like to tap into superannuation 
but can't without tax penalty. Govemment resources not helpful as have 
insufficient advice, insufficient and incorrect advice about equipment. 
15. Sceptical about what services are provided - nothing works and there is no 
use in accessing anything. Would like to see alternative therapists have 
some sort of validates certificate so not quacks and patients can know who 
to trust and not get ripped off. Support from the Housing commission is good 
and helpful. Traditional and non traditional practitioners are antagonistic to 
each other and should work together for the good of the patients. 
16. Feels main needs met however found it hard to know who is a good 
neurologist - would like a list of recommended neurologists interested and 
good at treating ms. Also trying to find supportive and helpful general 
practitioners is a challenge. 
17. Everything OK at moment and gets home help 4 hours a week paid for. 
Information from the mssq is too confusing and really she doesn't want to 
know all the bad news. Also still driving but she should give it up as too bad 
but worried about alternative with transport - how to get around. Frustration 
in activities of daily living and relies on her 10 year old daughter to cook and 
help around the house. 
18. OK with things but cost of incontinence pads are expensive and only a $500 
yearly limit which should be increased. Need more subsidies. 
19. Need heated pool close to home for hydrotherapy and having the disable 
parking sticker is absolutely wonderful!!! Likes taking complementary 
therapy as she is in control of her MS. However finds ms very depressing 
and feels guilty because she is not as bad as everyone else with MS. She 
has fear of ending up like that she doesn't like getting information from the 
MSSQ etc. stays separate from other people with ms. 
20. Access points for some service industries do not have entrances for 
disabled people. Also she is not aware of all the services available for 
people with MS and would like some proactive information given to medical 
practitioners to educate them Some of the tests for MS are very debilitating 
and depressing. 
21. Feels that people in the outer areas of Brisbane and regional areas of Qld 
miss out on some services. When he needs braces for his legs he must 
travel to city for the service. 
22. Would like easier access to information and better support network for 
carers. Transport to Brisbane is costly and problems with bowel and bladder 
can be awkward in the plane or bus. Would like more information about adi 
skills put into place in regional areas. Also, when diagnosed would like 
information on potential problems for people with MS. Children of parents 
with MS need to understand the issues involved. 
23. Would like GPs better educated and also local health facilities when you 
don't live in Brisbane city. Need a good physio who is close to the regional 
centres. In local areas outside of main cities there is very little education and 
awareness about ms and the needs of people with ms. When diagnosed it 
would be useful to have phone numbers of services and providers for people 
with MS. 
24. Uses the hydrotherapy pool in local community and joined a group of other 
people with disabilities. Has great support and feels that both family and 
friends are supportive. 
25. Would like easier access for public toilets and wheelchair access to shops 
and facilities. Better car parking would be appreciated. 
26. Didn't like going to the mssq because everyone in wheelchairs and it was 
frightening. She would like two groups where less disabled people could not 
be frightened. 
27. Happy with status quo. Has supportive wife and is happy with DSS, 
hospital, etc. 
28. Feels services are adequate and doesn't want anything else at the moment. 
MSSQ good for moral support. 
29. Mobility allowances very restrictive. Feels there is a lack of information 
about MS for the carers. Would like access to up to date information about 
MS research and treatments and services . 
30. No complaints - has access to taxi vouchers and managing well. Everything 
has improved now when compared to years ago. Would like home help for 
washing. 
31. No availability for services in regional centres. Transport for getting to 
physio of other services very expensive and time consuming. Wants local 
services... Would not go to mssq and believes in helping myself need help 
for carers who look after people with bad disease. 
32. Things are OK. Has had good support from local nurses and has taxi 
vouchers which help with the transport. 
33. Too far to access MSSQ in Brisbane city - would like regional help. Family 
members of people with ms need special consideration and a social worker 
is necessary to discuss some of the issues and how to resolve. Also a 
multidisciplinary clinic would be good idea so that holistic help is forthcoming. 
34. Lives in outer suburbs and MSSQ too far to travel to. Would like to chat and 
meet with others. Enjoys meeting with others in the support group for MS. 
35. Happy and does not need any help 
36. Often is very depressing in support groups. When on holidays it is very 
difficult to get suitable accommodation for wheelchairs. Toilet facilities when 
travelling are not good. GPs are not educated about MS and are not aware 
of the issues involved. They need educating. 
37. Transport can be a problem. Prefers to stay away from others with MS as 
they are too morbid and better to get on with life. Husband works therefore 
she does not qualify for home help - unlucky. Husband works therefore no 
help from government. 
38. Satisfied with services at present time. Has supportive family. 
39. Carers need more support both emotionally and monetary. Need to know 
about tax exempt items and how to acquire things for daily life 
improvements. GPs are not educated about MS and need to know more 
also physiotherapists and other health professionals need information on 
MS. Quality of health professional varies dramatically from person to person. 
40. Transport issues are difficult but feels that has adequate support and help. 
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